Approved Products List ( Kedar Drugs & Pharmaceuticals Pvt. Ltd.) | ||||
S. No | Generic Name | Composition | ||
1 | Acamprosate calcium tabs 333 mg | Each enteric coated tab contains; Acamprosate calcium 333 mg Excipients q.s. ,Colour: Titanium Dioxide & Yellow iron oxide | ||
2 | Acebrophylline SR Tablet 200 mg | Each
film coated SR tablet contains: Acebrophylline 200 mg Excipients: QS Colour Approved Colour |
||
3 | Acebrophylline Sustained Release Tablets 200 mg | Each
film coated tablet contains: Acebrophylline 200 mg (As Sustained Release) Excipients q.s Colour: Titanium Dioxide IP |
||
4 | Aceclofenac 100 mg & Paracetamol 500 mg Tablets | Each
film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 500 mg Colours: Ferric Oxide (Yellow) USPNF & Titanium Dioxide IP |
||
5 | Aceclofenac Tablets IP 100 mg | Each
film coated Tablet contains; Aceclofenac IP.. 100 mg Excipients ..q.s. Colour: Titanium Dioxide IP |
||
6 | Acotiamide Tablets 100 mg | Each Film Coated Tablet Contains: Acotiamide Hydrochloride Hydrate 100 mg Excipients q.s. Colour: Yellow Iron oxide and Titanium Dioxide IP | ||
7 | Ademetionine Tablets 200 mg | Each
Enteric Coated Tablet Contains: Ademetionine 1, 4-butane disulfonate (SD4) equivalent to Ademetionine 200 mg Colour: Approved Colour |
||
8 | Ademetionine Tablets 400 mg | Each
Enteric Coated Tablet Contains: Ademetionine 1, 4-butane disulfonate (SD4) equivalent to Ademetionine 400 mg Colour: Approved Colour |
||
9 | Alogliptin Tablet 12.5 mg | Each
film coated tablet contains: Alogliptin .. ..12.25 mg Excipients: q.s,, Colour: Ferric Oxide Yellow |
||
10 | Alogliptin Tablet 25 mg | Each
film coated tablet contains: Alogliptin .. .25 mg Excipients: q.s, Colour: Ferric Oxide Red |
||
11 | Alogliptin Tablet 6.25 mg | Each
film coated tablet contains: Alogliptin .. ..6.25 mg Excipients: q.s,, Colour: Sunset Yellow |
||
12 | Alpha Lipoic Acid, Pyridoxine Hydrochloride, Methylcobalamin, Folic Acid & Benfotiamine Capsules | Each
soft gelatin capsule contains: Alpha Lipoic Acid USP 100mg Pyridoxine Hydrochloride IP 3 mg Methylcobalamin IP 1500 mcg Folic Acid IP 1.5 mg Benfotiamine 100 mg Excipients q.s. |
||
13 | Alprazolam Dispersible tablet 0.125 mg | Each
uncoated Dispersible tablet contains: Alprazolam 0.125 mg |
||
14 | Alprazolam Dispersible tablet 0.25 mg | Each
uncoated Dispersible tablet contains: Alprazolam 0.25 mg |
||
15 | Alprazolam Dispersible tablet 0.50 mg | Each
uncoated Dispersible tablet contains: Alprazolam 0.50 mg |
||
16 | Alprazolam SR 0.25 mg + Sertraline Hcl 25 mg Bilayer Tablet | Each
uncoated Bilayer tablet contains: Alprazolam 0.25 mg (SR) Sertraline Hcl 25 mg |
||
17 | Alprazolam SR 0.25 mg + Sertraline Hcl 50 mg Bilayer Tablet | Each
uncoated Bilayer tablet contains: Alprazolam 0.25 mg (SR) Sertraline Hcl 50 mg |
||
18 | Alprazolam SR tablet 0.5 mg | Each
uncoated SR tablet contains: Alprazolam 0.5 mg |
||
19 | Alprazolam SR tablet 1.5 mg | Each
uncoated SR tablet contains: Alprazolam 1.5 mg |
||
20 | Alprazolam Sublingual Tablet 0.5 mg | Each
uncoated sublingual tablet contains: Alprazolam 0.5 mg |
||
21 | Alprazolam Sublingual Tablet 1.0 mg | Each
uncoated sublingual tablet contains: Alprazolam 1.0 mg |
||
22 | Alprazolam tablet 0.25 mg | Each
uncoated tablet contains: Alprazolam 0.25 mg |
||
23 | Alprazolam tablet 0.50 mg | Each
uncoated tablet contains: Alprazolam 0.50 mg |
||
24 | Alprazolam tablet 1.0 mg | Each
uncoated tablet contains: Alprazolam 1.0 mg |
||
25 | Amantadine Hydrochloride Tablets 100 mg | Each uncoated tablet contains: Amantadine Hydrochloride IP 100 mg Excipients q.s | ||
26 | Amisulpride 300 mg tablets | Each uncoated tablet contains: Amisulpride IP 300 mg Excipients: q.s., Colour Yellow Oxide of Iron | ||
27 | Amisulpride tablet 100 mg | Each uncoated Tablet contains: Amisulpride IP . 100 mg Excipients: QS, Colour: Ponceau 4R | ||
28 | Amisulpride tablet 100 mg | Each uncoated Tablet contains: Amisulpride IP 100 mg Excipients: QS Colour: Yellow Oxide of Iron | ||
29 | Amisulpride tablet 200 mg | Each uncoated Tablet contains: Amisulpride IP 200 mg Excipients: QS Colour: Yellow Oxide of Iron | ||
30 | Amisulpride tablet 400 mg | Each uncoated Tablet contains: Amisulpride IP 400 mg Excipients: QS Colour: Yellow Oxide of Iron | ||
31 | Amisulpride tablet 400 mg | Each
uncoated Tablet contains: Amisulpride IP ..400 mg Excipients .. .. . q.s. |
||
32 | Amisulpride tablet 50 mg | Each uncoated Tablet contains: Amisulpride IP 50 mg Excipients: QS Colour: Yellow Oxide of Iron | ||
33 | Amitriptyline HCI Tablets IP 10 mg | Each
film coated tablet contains: Amitriptyline HCI IP 10 mg Excipients q.s. |
||
34 | Amitriptyline HCI Tablets IP 25 mg | Each
film coated tablet contains: Amitriptyline HCI IP 25 mg Excipients q.s. |
||
35 | Amitriptyline HCI Tablets IP 50 mg | Each
film coated tablet contains: Amitriptyline HCI IP 50 mg Excipients q.s. |
||
36 | Amlodipine (As besylate) 10 mg + Valsartan 160 mg tablet IP | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine 10 mg Valsartan 160 mg Excipients q.s. Colour: Titanium Dioxide & Sunset yellow | ||
37 | Amlodipine (As besylate) 5 mg + Valsartan 160 mg tablet IP | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine 5 mg Valsartan 160 mg Excipients q.s. Colour: Titanium Dioxide | ||
38 | Amlodipine (As besylate) 5 mg + Valsartan 80 mg tablet IP | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine 5 mg Valsartan 80 mg Excipients q.s. Colour: Titanium Dioxide & Red iron oxide | ||
39 | Amlodipine 10 mg and Indapamide 1.5 mg (SR) Tablets | Each
uncoated Bilayered Tablet Contains: Amlodipine Besylate IP Equivalent to Amlodipine 10 mg Indapamide IP 1.5 mg (As sustained Release Form ) Excipients q.s |
||
40 | Amlodipine 2.5 mg + Valsartan 80 mg + HCTZ 12.5 mg tablet | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine 2.5 mg Valsartan 80 mg Hydrochlorothiazide 12.5 mg Excipients q.s. Colour: Titanium Dioxide & Ponceau 4R | ||
41 | Amlodipine 5 mg + Valsartan 320 mg + HCTZ 12.5 mg tablet | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine 5 mg Valsartan 320 mg Hydrochlorothiazide 12.5 mg Excipients q.s. Colour: Titanium Dioxide | ||
42 | Amlodipine 5 mg and Indapamide 1.5 mg (SR) Tablets | Each
uncoated Bilayered Tablet Contains: Amlodipine Besylate IP Equivalent to Amlodipine 5 mg Indapamide IP 1.5 mg (As sustained Release Form ) Excipients q.s |
||
43 | Amlodipine and Benazepril HCLCapsules USP | Each
capsule contains: Amlodipine (as besylate). Equivalent to Amlodipine . 2.5mg. Benazepril HCL USP ..10mg |
||
44 | Apomorphine HCL 2 mg Sublingual tablet | Each uncoated Sublingual tablet contains: Apomorphine HCL 2 mg Excipients: QS | ||
45 | Apomorphine HCL 3 mg Sublingual tablet | Each uncoated Sublingual tablet contains: Apomorphine HCL 3 mg Excipients: QS | ||
46 | Armodafinil tablet 150 mg | Each uncoated tablet contains; Armodafinil 150 mg, Excipients q.s. | ||
47 | Armodafinil tablet 250 mg | Each uncoated tablet contains; Armodafinil 250 mg , Excipients q.s. | ||
48 | Armodafinil tablet 50 mg | Each uncoated tablet contains; Armodafinil 50 mg, Excipients q.s. | ||
49 | Atorvastatin 10 mg & Fenofibrate 160 mg Tablets IP | Each
film coated tablet contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 10 mg Fenofibrate IP 160 mg Excipients: q.s. Colour : Ferric Oxide Red USP NF, Titanium Dioxide IP |
||
50 | Atorvastatin 10 mg & Fenofibrate 160 mg Tablets IP | Each film coated tablet contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 10 mg Fenofibrate IP 160 mg Excipients q.s Colour : Approved, Titanium Dioxide IP | ||
51 | Azilsartan 40 mg Tablet | Each
uncoated tablet contains: Azilsartan kamedoxil eq. To Azilsartan Medoxomil 40 mg Excipients q.s |
||
52 | Azilsartan 80 mg Tablet | Each
uncoated tablet contains: Azilsartan kamedoxil eq. To Azilsartan medoxomil 80 mg Excipients q.s |
||
53 | Baclofen 10 mg tablet | Each uncoated tablet contains: Baclofen 10 mg Excipients: QS | ||
54 | Baclofen 10 mg Tablets IP | Each
uncoated Tablet contains: Baclofen IP ..10 mg Excipients .. .. . q.s. |
||
55 | Baclofen 20 mg tablet | Each
Uncoated Extended Release Tablets Contains:: Baclofen .. ..20 mg Excipients: q.s. |
||
56 | Baclofen 25 mg tablet | Each uncoated tablet contains: Baclofen 25 mg Excipients: QS | ||
57 | Baclofen E.R capsule 30mg | Each Filled ER capsule contains: Baclofen E.R 30 mg Excipients: q.s, |
||
58 | Baclofen Extended Release (GRS) Tablets | Each
Uncoated extended release (GRS) Tablet contains: Baclofen IP 30 mg Excipients ..q.s |
||
59 | Baclofen Extended Release Tablets 20 mg | Each
uncated Sustained Release tablet contains : Baclofen IP .20 mg Excipients .. .. . q.s. |
||
60 | Baclofen
Extended Release tablet 30 mg |
Each
uncoated extended release tablet contains: Baclofen 30 mg Excipients: . QS |
||
61 | Baclofen Sustained Release Tablets 30 mg | Each
uncated Sustained Release tablet contains : Baclofen IP .30 mg Excipients .. .. . q.s. |
||
62 | Benazepril HCL and Hydrochlorthiazide Tablets | Each
film coated Tablet contains; Benazepril HCL 20 mg Hydrochlorthiazide ...................25 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
63 | Benazepril HCL Tablets 10 mg | Each
film coated Tablet contains; Benazepril HCL USP 10 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
64 | Benazepril HCL Tablets 10 mg | Each
film coated Tablet contains; Benazepril HCL USP 10 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
65 | Benazepril HCL Tablets 20 mg | Each
film coated Tablet contains; Benazepril HCL USP 20 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
66 | Benazepril HCL Tablets 20 mg | Each
film coated Tablet contains; Benazepril HCL USP 20 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
67 | Benazepril HCL Tablets 5 mg | Each
film coated Tablet contains; Benazepril HCL USP 5 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
68 | Benazepril HCL Tablets 5 mg | Each
film coated Tablet contains; Benazepril HCL USP 5 mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
69 | Benfotiamine, Alpha Lipoic Acid, Inositol, Mecobalamin, Folic Acid, Chromium Tablet | Each
Film coated tablet contains: Benfotiamine .150 mg Alpha Lipoic Acid 100 mg Inositol USP-NF 100 mg Mecobalamin IP .1.5 mg Folic Acid IP ..1.5 mg Chromium ..0.2 mg (as chromium polynicotinate) Excipients q.s. |
||
70 | Betahistine Di hydrochloride CR capsule 24 mg | Each
uncoated CR tablet contains: Betahistine Hydrochloride IP 32 mg Excipients: qs |
||
71 | Betahistine Di hydrochloride CR capsule 32 mg | Each
uncoated CR tablet contains: Betahistine Hydrochloride IP 32 mg Excipients: qs |
||
72 | Betahistine Di hydrochloride CR capsule 48 mg | Each
uncoated CR tablet contains: Betahistine Hydrochloride IP 48 mg Excipients: qs |
||
73 | Betahistine Hydrochloride SR Tablets IP 24 mg | Each
uncoated SR tablet contains: Betahistine Hydrochloride IP 24 mg Excipients q.s. |
||
74 | Betahistine Hydrochloride SR Tablets IP 32 mg | Each
uncoated SR tablet contains: Betahistine Hydrochloride IP 32 mg Excipients: qs |
||
75 | Betahistine Hydrochloride SR Tablets IP 48 mg | Each
uncoated SR tablet contains: Betahistine Hydrochloride IP 48 mg Excipients: qs |
||
76 | Betahistine Hydrochloride Tablets IP 16 mg | Each
uncoated tablet contains: Betahistine Hydrochloride IP 16 mg Excipients q.s. |
||
77 | Betahistine mesylate 12 mg Tablet | Each
tablet contains; Betahistine mesilate- 12mg |
||
78 | Betahistine mesylate 6 mg Tablet | Each
tablet contains; Betahistine mesilate-6mg, 12mg |
||
79 | Bisoprolol Fumarate 2.5 mg and Amlodipine Besylate 5 mg Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 2. 5 mg Amlodipine Besylate IP Eq. To Amlodipine 5 mg Excipients q.s. Colours : Titanium Dioxide IP | ||
80 | Bisoprolol Fumarate 2.5 mg and Hydrochlorthiazide 6.25 mg Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 2. 5 mg Hydrochlorthiazide 6.25 mg Excipients q.s. Colours : Titanium Dioxide IP | ||
81 | Bisoprolol Fumarate 5 mg and Amlodipine Besylate 5 mg Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Equivalent To Amlodipine 5 mg Excipients q.s. , Colours : Titanium Dioxide IP | ||
82 | Bisoprolol Fumarate 5 mg and Hydrochlorthiazide 6.25 mg Tablets | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 5 mg Hydrochlorthiazide 6.25 mg Excipients q.s. Colours : Titanium Dioxide IP | ||
83 | Bisoprolol Fumarate Tablets 10 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 10 mg Excipients q.s Colours: Yellow oxide of Iron and Titanium Dioxide IP | ||
84 | Bisoprolol Fumarate Tablets 2.5 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 2.5 mg Excipients q.s Colour: Titanium Dioxide IP | ||
85 | Bisoprolol Fumarate Tablets 5 mg | Each Film Coated Tablet Contains : Bisoprolol Fumarate IP 5 mg Excipients q.s Colours: Yellow oxide of Iron and Titanium Dioxide IP | ||
86 | Buprenorphine and Naloxone sublingual tablets IP 0.4 mg & 0.1 mg | Each
uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Equivalent to Buprenorphine 0.4 mg Naloxone Hydrochloride 0.1 mg Exciepients q.s |
||
87 | Buprenorphine and Naloxone sublingual tablets IP 2.0 mg & 0.5 mg | Each
uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Equivalent to Buprenorphine 2.0 mg Naloxone Hydrochloride 0.5 mg Exciepients q.s |
||
88 | Buprenorphine sublingual tablets IP 0.2 mg | Each
uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Equivalent to Buprenorphine 0.2 mg Exciepients q.s |
||
89 | Buprenorphine sublingual tablets IP 0.4 mg | Each
uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Equivalent to Buprenorphine 0.4 mg Exciepients q.s |
||
90 | Buprenorphine sublingual tablets IP 2.0 mg | Each
uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Equivalent to Buprenorphine 2.0 mg Exciepients q.s |
||
91 | Bupropion Hydrochloride Prolonged-release Tablets IP | Each
film coated bilayered prolonged-release tablet contains: Bupropion Hydrochloride IP ..150 mg Excipients: q.s , Colour: Sunset Yellow FCF |
||
92 | Cabergoline Tablets I.P. 0.5 mg | Each uncoated tablet contains: Cabergoline IP 0.5 mg, Excipients q.s. | ||
93 | Cabergoline Tablets I.P. 1 mg | Each uncoated tablet contains: Cabergoline IP 1 mg, Excipients q.s. | ||
94 | Canagliflozin 100 mg Tablet | Each
film coated tablet contains: Canagliflozin 100 mg Excipients: q.s, Colour: Titanium Dioxide, Ferric Oxide Yellow |
||
95 | Canagliflozin 300 mg Tablet | Each
film coated tablet contains: Canagliflozin 300 mg Excipients: q.s, Colour: Titanium Dioxide |
||
96 | Carbamazepine Prolonged-release Tablets IP 200 mg | Each uncoated prolonged-release tablet contains: Carbamazepine IP 200 mg, Excipients q.s. | ||
97 | Carbamazepine Prolonged-release Tablets IP 400 mg | Each uncoated prolonged-release tablet contains: Carbamazepine IP 400 mg, Excipients q.s. | ||
98 | Chlordiazepoxide Tablets I.P. 10 mg | Each
fiim contad tablet contans: Chiondazspoxide IP 10 mg Excipients : q.s., Colour Titanium Dioxide IP |
||
99 | Chlordiazepoxide Tablets I.P. 25 mg | Each
fiim contad tablet contans: Chiondazspoxide IP . 25 mg Excipients q.s., Colour Titanium Dioxide IP |
||
100 | Chlordiazepoxide Tablets IP 10 mg | Each
film coated tablet contains: Chlordiazepoxide ..10 mg Excipients .. .. . q.s. |
||
101 | Cilnidipine 10 mg Tablets | Each
uncoated tablet contains: Cilnidipine IP 10 mg Excipients q.s |
||
102 | Cilnidipine 5 mg Tablets | Each
uncoated tablet contains: Cilnidipine IP 5 mg Excipients q.s |
||
103 | Cilostazol Tablet IP 100 mg | Each
Uncoated Tablet Contains: Cilostazol IP 100 mg Excipients q.s |
||
104 | Cilostazol Tablet IP 50 mg | Each
Uncoated Tablet Contains: Cilostazol IP 50 mg Excipients q.s |
||
105 | Cilostazole E.R Tablet 100mg | Each
Coated ER tablet contains: Cilostazol IP 100 mg Excipients q.s Colour: Approved Colour |
||
106 | Cilostazole E.R Tablet 200 mg | Each
Coated ER tablet contains: Cilostazol IP 100 mg Excipients q.s Colour: Approved Colour |
||
107 | Cinacalcet Tablets 30 mg | Each film coated tablets contains: Cinacalcet Hydrochloride IP Eq. to Cinacalcet 30 mg Excipients q.s , Colours: Sunset Yellow & Titanium Dioxide IP | ||
108 | Cinacalcet Tablets 60 mg | Each film coated tablets contains: Cinacalcet Hydrochloride IP Eq. to Cinacalcet 60 mg Excipients q.s Colours: Red Iron Oxide & Titanium Dioxide IP | ||
109 | Cinacalcet Tablets 90 mg | Each film coated tablets contains: Cinacalcet Hydrochloride IP Eq. to Cinacalcet 90 mg Excipients q.s , Colours: Iron Oxide Yellow & Titanium Dioxide IP | ||
110 | Cinnarizine 15.0 mg Tablets | Each
uncoated tablet contains: Cinnarizine IP 15 mg Excipients q.s |
||
111 | Cinnarizine 20.0 mg and Dimenhydrinate 15.0 mg Tablets | Each
uncoated tablet contains: Cinnarizine IP 20 mg Dimenhydrinate BP 15 mg Excipients q.s |
||
112 | Cinnarizine 20.0 mg and Dimenhydrinate 40.0 mg Tablets | Each
uncoated tablet contains: Cinnarizine IP 20 mg Dimenhydrinate BP 40 mg Excipients q.s |
||
113 | Cinnarizine 25.0 mg Tablets | Each
uncoated tablet contains: Cinnarizine IP 25 mg Excipients q.s |
||
114 | Cinnarizine 75 mg SR tablets | Each
coated tablet contains: cinnarizine-75 mg Excipients q.s |
||
115 | Citicoline 200 mg Tablets | Each
Film Coated Tablet Contains: Citicoline Sodium IP Equivalent To Citicoline 200 mg Excipients q.s. Colour: Approved Colour, Titanium Dioxide IP |
||
116 | Citicoline 500 & Piracetam 800 Tablets | Each
film coated tablet contains : Citicoline Sodium IP eq to Citicoline .500 mg Piracetam IP ... 800 Excipients .. .. . q.s. Colours: Red Oxide of Iron & Titanium Dioxide IP |
||
117 | Citicoline 500 mg + Piracetam 400 mg Tablets | Each
film coated tablet contains:
Citicoline Sodium IP eq. to Citicoline 500 mg Piracetam IP .400 mg Excipients: q.s, Colours: Yellow Oxide of Iron & Titanium Dioxide IP |
||
118 | Citicoline Chewable tablet (500mg) | Each
uncoated Chewable Tablet Contains: Citicoline Sodium IP Equivalent To Citicoline 500 mg Excipients q.s. |
||
119 | Citicoline CR Tab 1000 mg | Each Coated Control release tablets contains: Citicoline 1000 mg Excipients q.s , Colours: Sunset Yellow & Titanium Dioxide IP | ||
120 | Clarithromycin tablet 250 mg | Each
film coated tablet contains; Clarithromycin 250 mg Excipients q.s. Colour: Titanium Dioxide |
||
121 | Clarithromycin tablet 500 mg | Each
film coated tablet contains; Clarithromycin 500 mg, Excipients q.s. Colour: Titanium Dioxide |
||
122 | Clobazam Mouth Dissolving Tablets 5 mg | Each
Uncoated Mouth Dissolving Tablet Contains: Clobazam IP 5 mg Excipients q.s. |
||
123 | Clobazam Mouth Dissolving Tablets 10 mg | Each
uncoted Mouth Dissolving Tablet Contains: Clobazam IP 10 mg |
||
124 | Clonazepam Mouth Dissolving tablets 0.25 mg | Each uncoated mouth dissolving tablet contains: Clonazepam IP 0.25 mg | ||
125 | Clonazepam Mouth Dissolving tablets 0.50 mg | Each
uncoated mouth dissolving tablet contains Clonazepam IP 0.5 mg |
||
126 | Clonazepam Mouth Dissolving tablets 1.00 mg | Each
uncoated mouth dissolving tablet contains Clonazepam IP 1.00 mg |
||
127 | Clonazepam Mouth Dissolving tablets 2.00 mg | Each
uncoated mouth dissolving tablet contains Clonazepam IP 2.00 mg |
||
128 | Clonazepam tablet 0.50 mg | each uncoated tablet contains: Clonazepam IP 0.50 mg | ||
129 | Clonazepam tablet 0.25 mg | each uncoated tablet contains: Clonazepam IP 0.25 mg | ||
130 | Clonazepam tablet 1.00 mg | each uncoated tablet contains: Clonazepam IP 1.00 mg | ||
131 | Clonazepam tablet 2.00 mg | each uncoated tablet contains: Clonazepam IP 2.00 mg | ||
132 | Clonidin Hcl-100 mcg+ Hydrochlorthiazide-20 mg Tablet | Each
Tablet Contains:
Clonidin Hcl-100 mcg Hydrochlorthiazide-20 mg Excipient : QS |
||
133 | Clonidine 0.1 mg + Chlorthalidone 15 mg tablet | Each
tablet contains;
Clonidine hcl BNF- eq. to Clonidine 0.1 mg, Chlorthalidone IP-15 mg , Excipient : QS |
||
134 | Clonidine 0.2 mg + Chlorthalidone 15 mg tablet | Each
tablet contains; Clonidine hcl BNF- eq. to Clonidine 0.2mg, Chlorthalidone IP-15 mg Excipient : QS |
||
135 | Clonidine Hcl Tablet 0.15 mg | Each
tablet contains;
Clonidine Hcl-0.15mg Excipient : QS |
||
136 | Clopidogrel 300 mg & Aspirin 150 mg Tablets IP | Each film coated bilayered tablet contains : Clopidogrel Bisulphate Equivalent To Clopidogrel 300 mg IP Aspirin IP 150 mg Excipients q.s , Colour : Red Oxide Of Iron and Titanium Dioxide IP | ||
137 | Clozapine Tablets 50 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..50 mg Excipients .. .. . q.s. |
||
138 | Clozapine Oro Dispersible tablets 12.5 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..12.5 mg Excipients .. .. . q.s. |
||
139 | Clozapine Oro Dispersible tablets 200 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..200 mg Excipients .. .. . q.s. |
||
140 | Clozapine Oro Dispersible tablets 25 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..25 mg Excipients .. .. . q.s. |
||
141 | Clozapine Oro Dispersible tablets 50 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..50 mg Excipients .. .. . q.s. |
||
142 | Clozapine Oro Dispersible tablets100 mg | Each
uncoated oro dispersible tablet
contains: Clozapine IP ..100 mg Excipients .. .. . q.s. |
||
143 | Clozapine Tablet 100 mg | Each uncoated tablet contains; Clozapine- 100 mg. ,Excipients: QS | ||
144 | Clozapine Tablet 200 mg | Each uncoated tablet contains; Clozapine- 200 mg. ,Excipients: QS | ||
145 | Clozapine Tablet 25 mg | Each uncoated tablet contains; Clozapine- 25 mg. , Excipients: QS | ||
146 | Clozapine Tablet IP 12.5 mg | Each
uncoated tablet contains: ClozapineIP 12.5 mg Excipients .. q.s. |
||
147 | Dapagliflozin Tablet 10 mg | Each
film coated tablet contains: Dapagliflozin propanediol monohydrate eq.to Dapagliflozin-10 mg Excipients q.s. Colour: Approved Colour, Titanium Dioxide IP 5 mg, 10mg |
||
148 | Dapagliflozin Tablet 10 mg | Each
film Coated tablet contains; Dapagliflozin propanediol monohydrate eq.to dapagliflozin ..10 mg Excipients q.s, Colour: Titanium Dioxide & Iron Oxide Red |
||
149 | Dapagliflozin Tablet 5 mg | Each
film coated tablet contains: Dapagliflozin propanediol monohydrate eq.to dapagliflozin-5 mg Excipients q.s. Colour: Approved Colour, Titanium Dioxide IP |
||
150 | Dapagliflozin Tablet 5 mg | Each
film coated tablet contains; Dapagliflozin propanediol monohydrate eq.to dapagliflozin .5 mg Excipients q.s, Colour: Titanium Dioxide & Iron Oxide Yellow |
||
151 | Desvenlafaxine 100 mg tablet | Each Film Coated Extended release Tablet Contains: Desvenlafaxine Succinate USP eq. to Desvenlafaxine 100 mg Excipients: QS Colour: Yellow Oxide of Iron & Titanium Dioxide IP | ||
152 | Desvenlafaxine 25 mg tablet | Each film coated Extended release tablet contains: Desvenlafaxine succinate 25mg Excipients: QS Colour: Approved Colour & Titanium Dioxide IP | ||
153 | Desvenlafaxine 50 mg tablet | Each Film Coated Extended release Tablet Contains: Desvenlafaxine Succinate USP eq. to Desvenlafaxine 50 mg Excipients: QS Colour: Approved Colour & Titanium Dioxide IP | ||
154 | Desvenlafaxine 50 mg + Clonazepam 0.25 mg tablet | Each
uncoated Bilayer tablet Contains: Desvenlafaxine .. 50 mg Clonazepam ..0.25 mg Excipients: q.s., Colour: Red iron Oxide (Desvenlafaxine Layer) |
||
155 | Desvenlafaxine ER 50 mg + Clonazepam 0.5 mg Tab | Each
uncoated Bilayer tablet Contains: Desvenlafaxine ER .. .. 50 mg Clonazepam ..0.5 mg Excipients: q.s. Colour: Quinoline Yellow (Desvenlafaxine Layer) |
||
156 | Desvenlafaxine Extended release and Clonazepam tablets | Each
uncoated bilayered tablet contains: Desvenlafaxine Succinate USP Eq.to Desvenlafaxine .50 mg (as extended release form) Clonazepam IP ..0.5 mg Excipients ..q.s Colour: Quinoline Yellow WS |
||
157 | Dexrabeprazole 10mg (EC) + Domperidone 30mg SR Capsules | Each filled capsule contains: Dexrabeprazole . ..20 mg Domperidone SR . . .. ..30 mg | ||
158 | Diclofenac Potassium 50 mg & Metaxalone400 mg Tablets | Each
film coated tablet contains : Diclofenac Potassium BP 50 mg Metaxalone 400 mg Excipients q.s. |
||
159 | Diclofenac Sodium 50 mg + Codeine Phosphate 50 mg tablets | Each
uncoated tablet contains: Diclofenac Sodium IP 50 mg Codeine Phosphate IP 50 mg Excipients: QS |
||
160 | Diclofenac Sodium 50 mg + Paracetamol 325 mg tablets | Each
coated tablet contains; Diclofenac Sodium - 50 mg, Paracetamol- 325 mg Excipients: QS Colour: Titanium Dioxide |
||
161 | Disulfiram Tablets IP 250 mg | Each
uncoated tablet contains: Disulfiram IP ..250 mg Excipients .. .. . q.s. |
||
162 | Divalproex Sodium Extended Release Tablets IP 1000 mg | Each
extended release tablet contains: Divalproex sodium IP Eq. to Valproic Acid 1000 mg, Excipients q.s. |
||
163 | Divalproex Sodium Extended Release Tablets IP 250 mg | Each
extended release tablet contains: Divalproex sodium IP Eq. to Valproic Acid 250 mg Excipients q.s. |
||
164 | Divalproex Sodium Extended Release Tablets IP 500 mg | Each
film coated extended release tablet contains: Divalproex sodium IP Eq. to Valproic Acid 500 mg Excipients q.s. |
||
165 | Divalproex Sodium Extended Release Tablets IP 750 mg | Each
film coated extended release tablet contains: Divalproex sodium IP Eq. to Valproic Acid 750 mg Excipients q.s. |
||
166 | Domperidone and Naproxen sodium tablets 10 mg & 500 mg | each film coated tablet contains: Domperidone Maleate IP, equivalent to Domperidone 10 mg, Naproxen sodium USP 550 mg, Equvilent to Naproxen 500 mg , excipient q.s. , colour: Red oxide of iron & titanium dioxide IP | ||
167 | Donepezil Hydrochloride 5 mg & Memantine Hydrochloride 10 mgTablets | Each
Film Coated Tablet Conatins: Memantine Hydrochloride IP 10 mg Donepezil Hydrochloride IP 5 mg Excipients q.s. |
||
168 | Donepezil Hydrochloride 5 mg & Memantine Hydrochloride 5 mg Tablets | Each
Film Coated Tablet Conatins: Memantine Hydrochloride IP 5 mg Donepezil Hydrochloride IP 5 mg Excipients q.s. |
||
169 | Doxofylline 400 mg + Ambroxol 30 mg Tablets | Each
uncoated tablet Contains : Doxofylline IP 400 mg Ambroxol IP 30 mg Excipients q.s |
||
170 | Doxofylline ER tablets 800 mg | Each
uncoated Extended Release tablet Contains : Doxofylline IP 800 mg Excipients q.s |
||
171 | Doxofylline ER tablets 400 mg | Each
uncoated Extended Release tablet Contains : Doxofylline IP 400 mg Excipients q.s |
||
172 | Doxofylline Modified Release 650 mg Tablets | Each
uncoated Modified Release tablet Contains : Doxofylline IP 650 mg Excipients q.s |
||
173 | Doxofylline Tablet 400 mg | Each
uncoated tablet Contains : Doxofylline IP 400 mg Excipients q.s |
||
174 | Doxophylline (SR) 400mg + Montelukast 10mg Tablets | Each Film Coated tablet Contains: Doxophylline (SR) 400 mg Montelukast 10 mg. Excipient : QS , Colour: Approved Colour | ||
175 | Doxophylline (SR) 800mg + Montelukast 10mg Tablets | Each Film Coated tablet Contains: Doxophylline (SR) 800 mg Montelukast 10 mg. Excipient : QS, Colour: Approved Colour | ||
176 | Duloxetine HCL Tablet 20 mg | Each Enteric Coated Tablet contains: Duloxetine Hydrochloride IP eq. to Duloxetine 20 mg Excipients: QS, Colour: Titanium Dioxide IP | ||
177 | Duloxetine HCL Tablet 30 mg | Each Enteric Coated Tablet contains: Duloxetine Hydrochloride IP eq. to Duloxetine 30 mg Excipients: QS, Colour: Titanium Dioxide IP | ||
178 | Duloxetine HCL Tablet 30 mg | Each
Enteric Coated Tablet contains:
Duloxetine Hydrochloride IP eq. to
Duloxetine
. 30 mg Excipients: q.s, Colour: Brilliant Blue |
||
179 | Duloxetine HCL Tablet 40 mg | Each Enteric Coated Tablet contains: Duloxetine Hydrochloride IP eq. to Duloxetine 40 mg Excipients: QS, Colour: Titanium Dioxide IP | ||
180 | Duloxetine HCL Tablet 60 mg | Each Enteric Coated Tablet contains: Duloxetine Hydrochloride IP eq. to Duloxetine 60 mg Excipients: QS, Colour: Titanium Dioxide IP | ||
181 | Duloxetine HCL Tablet 60 mg | Each
Enteric Coated Tablet contains:
Duloxetine Hydrochloride IP eq. to Duloxetine 60 mg Excipients: q.s,, Colour: Red Oxide of Iron |
||
182 | Emphagliflozin Tablet 10 mg | Each
film coated tablet contains; Empagliflozin ..10 mg Excipients: q.s, Colour: Titanium Dioxide |
||
183 | Emphagliflozin Tablet 25 mg | Each
film coated tablet contains; Empagliflozin ..25 mg Excipients: q.s, Colour: Titanium Dioxide |
||
184 | Epalrestat 50 mg + Methylcobalamin 500 mcg Tablets | Each
Film Coated Sustained release Tablet Contains: Epalrestat IP 50 mg Methylcobalamin IP 500 Mg Excipients q.s. Colour: Approved Colour, Titanium Dioxide IP |
||
185 | Eperison 150 mg SR Tab | Each film coated sustained release tablet contains: Eperisone Hydrochloride 150 mg Excipients: QS Colour: Titanium Dioxide IP | ||
186 | Eperisone 50 mg + Paracetamol 500 mg Tablets | Each film coated tablet contains: Eperisone Hydrochloride 50 mg Paracetamol 500 Excipients: QS Colour: Titanium Dioxide IP | ||
187 | Eperisone Tablet 50 mg | Each film coated sustained release tablet contains: Eperisone Hydrochloride 50 mg Excipients: QS Colour: Titanium Dioxide IP | ||
188 | Eplerenone Tablets IP 25 mg | Each
film coated tablet contains: Eplerenone IP 25 mg Excipients q.s Colour: Yellow Oxide of Iron and Titanium Dioxide IP |
||
189 | Eplerenone Tablets IP 50 mg | Each
film coated tablet contains: Eplerenone IP 50 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
||
190 | Escitalopram Oxalate & Clonazepam Tablet IP | Each
coated tablet contains: Escitalopram Oxalate
10 mg Clonazepam IP 0.5 mg Colour: Titanium dioxide IP |
||
191 | Escitalopram Oxalate & Clonazepam Tablets IP | each
film coated tablet contains Escitalopram Oxalate IP eq. to Escitalopram 10 mg Clonazepam IP 0.5 mg |
||
192 | Escitalopram Oxalate and Clonazepam Tablets IP | Each
film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 10 mg Clonazepam IP 0.25 mg |
||
193 | Escitalopram Oxalate and Clonazepam Tablets IP | Each
film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5 mg Clonazepam IP 0.5 mg |
||
194 | Escitalopram tablets 10 mg | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 10 mg , colour: Titanium dioxide IP | ||
195 | Escitalopram tablets 20 mg | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 20 mg , colour: Titanium dioxide IP | ||
196 | Escitalopram tablets 5mg | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5 mg , colour: Titanium dioxide IP | ||
197 | Esomeprazole EC + Domperidone SR capsules | Each filled capsule contains: Esomeprazole mag. eq.to Esomeprazole (as enteric coated pellets) 20 mg Domperidone maleate BP eq.to Domperidone (SR) 30mg . Excipients .q.s. | ||
198 | Esomeprazole EC + Domperidone SR capsules | Each filled capsule contains: Esomeprazole mag. eq.to esomeprazole (as enteric coated pellets) .40mg Domperidone maleate BP eq.to Domperidone (SR) 30mg . Excipients .q.s. | ||
199 | Esomeprazole magnesium Tablets 20 mg | Each enteric coated tablet contains; Esomeprazole magnesium eq.to Esomeprazole ..20 mg Excipients: q.s., Colour: Titanium Dioxide, Red iron oxide | ||
200 | Esomeprazole magnesium Tablets 40 mg | Each enteric coated tablet contains; Esomeprazole magnesiumveq.to Esomeprazole ..40mg Excipients: q.s., Colour: Titanium Dioxide, Yellow iron oxide | ||
201 | Etizolam & Propranolol Hydrochloride Tablets 0.25 mg & 20 mg | Each
Film coated Tablet contains Etizolam IP 0.25 mg Propranolol hydrochloride IP 20 mg |
||
202 | Etizolam & Propranolol Hydrochloride Tablets 0.25 mg & 20 mg | Each
film coated tablet contains: Etizolam IP 0.25 mg Propranolol Hydrochloride Colour: Titanium dioxide IP |
||
203 | Etizolam & Propranolol Hydrochloride Tablets 0.5 mg & 40 mg | Each
Film coated Tablet contains Etizolam IP 0.5 mg Propranolol hydrochloride IP 40 mg |
||
204 | Etizolam & Propranolol Hydrochloride Tablets 0.5 mg & 40 mg | Each
film coated tablet contains Etizolam IP 0.5gm Propranolol Hydrochloride IP 40 mg Colour: Titanium dioxide IP |
||
205 | Etizolam & Propranolol Hydrochloride Tablets 0.5mg & 20mg | Each
film coated tablet contains: Etizolam IP 0.5gm Propranolol Hydrochloride IP 20mg Colour: Titanium dioxide IP |
||
206 | Etizolam 1 mg Mouth Dissolving tablet | Each
Mouth Dissolving tablet contans: Etizolam .. 1 mg Excipiens: q.s. |
||
207 | Etizolam Mounth dissolving Tablets 0.25 mg | Each
uncoated mounth dissoling tablets contains Etizolam IP 0.25 mg |
||
208 | Etizolam Mounth dissolving Tablets 0.5 mg | Each
uncoated mounth dissoling tablets contains Etizolam IP 0.5 mg |
||
209 | Etizolam mouth dissolving Tablets 0.25 mg | Each
uncoated mouth dissolving tablet contains: Etizolam IP 0.25 mg Colour: Quinoline Yellow |
||
210 | Etizolam mouth dissolving Tablets 0.5 mg | Each
uncoated mouth dissolving tablet contains: Etizolam IP 0.5 mg Colour: Quinoline Yellow |
||
211 | Etizolam Tablet IP 1 mg | Each
coated tablet contains Etizolam IP 1 mg excipient q.s. Colour: Titanium dioxide IP |
||
212 | Etizolam Tablet IP 1 mg | Each
coated tablet contains: Etizolam IP 1 mg excipient q.s. Colour: Titanium dioxide IP |
||
213 | Etodolac and Tolperisone Hydrochloride Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Etodolac IP 400 mg Excipients q.s., Colour : Sunset Yellow FCF | ||
214 | Etoricoxib and Thiocolchicoside Tablets (60 mg + 4 mg) | Each
film coated tablet contains : Etoricoxib IP 60 mg Thiocolchicoside IP 4 mg |
||
215 | Fenofibrate Tablets IP 160 mg | Each
film coated tablet contains:
Fenofibrate IP 160 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
||
216 | Fexofenadine 120 mg + Montelukast 10 mg Tablet | Each Film Coated Tablet Contains: Fexofenadine 120 mg Montelukast 10 mg Excipients q.s | ||
217 | Fluoxetine Hydrochloride Capsule IP 20 mg | Each hard gelatin capsule contains: Fluoxetine Hydrochloride IP Eq to Fluoxetine 20 mg , excipient q.s , approved colour used in empty capsule shells | ||
218 | Fluoxetine Hydrochloride Capsule IP 60 mg | Each hard gelatin capsule contains:Fluoxetine Hydrochloride IP Eq to Fluoxetine 60 mg , excipient q.s, approved colour used in empty capsule shells | ||
219 | Flupirtine Maleate Capsules 100 mg | Each
hard gelatin capsule contains: Flupirtine Maleate 100 mg Excipients q.s. |
||
220 | Flupirtine Maleate Sustained Release Tablets 400 mg | Each uncoated SR tablet contains: Flupirtine Maleate 400 mg, Excipients q.s. | ||
221 | Fluvoxamine Maleate Extended Release Tablets 100 mg | Providing
Eicosapentaenoic Acid (EPA) 90 mg Docosahexaenoic Acid (DHA) 60 mg Green Tea Extract eq. to Polyphenols 10 mg |
||
222 | Gabapentin ER Tablets IP 300 mg | Each
film coated tablet contains: Gabapentin IP 300 mg Excipients q.s. |
||
223 | Gabapentin ER Tablets IP 400 mg | Each
coated tablet contains: Gabapentin IP 400 mg Excipients q.s. |
||
224 | Gliclazide 30 mg + Metformin 500 mg + Pioglitazone15 mg Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 30 mg Metformin HCl Eq. to Metformin IP 500 mg Pioglitazone IP 15 mg Excipients q.s. |
||
225 | Gliclazide 40 mg + Metformin 500 mg + Pioglitazone15 mg Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 40 mg Metformin HCl Eq. to Metformin IP 500mg Pioglitazone IP 15 mg Excipients q.s. |
||
226 | Gliclazide 40 mg + Metformin Hcl 500 mg + Rosiglitazone 2 mg tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 40 mg Metformin HCl Eq. to Metformin IP 500 mg Rosiglitazone IP 2 mg Excipients q.s. |
||
227 | Gliclazide 60 mg + Metformin 500 mg + Pioglitazone15 mg Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 60 mg Metformin HCl Eq. to Metformin IP 500 mg Pioglitazone IP 15 mg Excipients q.s. |
||
228 | Gliclazide 80 mg + Metformin 500 mg + Pioglitazone15 mg Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 80 mg Metformin HCl Eq. to Metformin IP 500 mg Pioglitazone IP 15 mg Excipients q.s. |
||
229 | Gliclazide 80 mg + Metformin Hcl 500 mg + Rosiglitazone 2 mg tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 80 mg Metformin HCl Eq. to Metformin IP 500 mg Rosiglitazone IP 2 mg Excipients q.s. |
||
230 | Gliclazide M.R. (30mg) + Metformin HCl (500mg) ER Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 30 mg Metformin HCl Eq. to Metformin IP 500mg Excipients q.s. |
||
231 | Gliclazide M.R. (60mg) + Metformin HCl (500mg) ER Tablet | Each
un-coated Bi-layer tablet Contains: Gliclazide IP 60 mg Metformin HCl Eq. to Metformin IP 500mg Excipients q.s. |
||
232 | Gliclazide Modified Release Tablets 30 mg | Each
uncoated modified Release Tablets Contains: Gliclazide IP 30 mg Excipients q.s. |
||
233 | Gliclazide Modified Release Tablets 60 mg | Each
uncoated modified Release Tablets Contains: Gliclazide IP 60 mg Excipients q.s. |
||
234 | Glimepiride 1 mg + Pioglitazone 30 mg tablet | Each
uncoated tab contains; Glimepiride .1 mg Pioglitazone HCL eq.to Pioglitazone ..30 mg, Excipients q.s, |
||
235 | Glimepiride 0.5 mg & Metformin Hydrochloride (SR) 500 mg Tablets IP | Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg Metformin Hydrochloride IP 500 mg (As SR) Colour: Red oxide iron (in Glimepiride layer) | ||
236 | Glimepiride 1 mg & Metformin Hydrochloride (SR) 1000 mg Tablets IP | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg (As SR) Colour: Sunset Yellow (in Glimepiride layer) | ||
237 | Glimepiride 1 mg & Metformin Hydrochloride (SR) 500 mg Tablets IP | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg (As SR) Colour: Ponceau 4R (in Glimepiride layer) | ||
238 | Glimepiride 2 mg & Metformin Hydrochloride (SR) 1000 mg Tablets IP | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP 1000 mg (As SR) Colour: Yellow Oxide iron (in Glimepiride layer) | ||
239 | Glimepiride 2 mg + Pioglitazone 30 mg tablet | Each
uncoated tab contains; Glimepiride .2 mg Pioglitazone HCL eq.to Pioglitazone ..30 mg, Excipients q.s, |
||
240 | Glimepiride Tablets IP 1 mg | Each
Uncoated Tablet Contains: Glimepiride IP 1 mg Excipients q.s |
||
241 | Glimepiride Tablets IP 2 mg | Each
Uncoated Tablet Contains: Glimepiride IP 2 mg Excipients q.s |
||
242 | Glimepiride Tablets IP 3 mg | Each
Uncoated Tablet Contains: Glimepiride IP 3 mg Excipients q.s |
||
243 | Glimepiride Tablets IP 4 mg | Each
Uncoated Tablet Contains: Glimepiride IP 4 mg Excipients q.s |
||
244 | Glipizide 2.5 mg + Metformin 250 tablets | Each
uncoated tablet contains; Glipizide ..2.5 mg Metformin . ...250 mg Excipients q.s, |
||
245 | Glipizide 2.5 mg and Metformin 250 mg tablets | Each
film coated tablet contains: Glipizide ..2.5 mg metformin ..250 mg Excipients: q.s, Colour: Titanium Dioxide |
||
246 | Glipizide 5 mg + Metformin 500 mg tablets | Each
uncoated tablet contains; Glipizide ..5 mg, Metformin ...500 mg Excipients q.s, |
||
247 | Glipizide 5 mg and Metformin 500 mg tablets | Each
film coated tablet contains; Glipizide ..5 mg, metformin ..500 mg Excipients: q.s, Colour: Titanium Dioxide, Ferric Oxide Yellow |
||
248 | Glipizide GITs tables 10 mg (gastro intestinal therapeutic sy | Each
film coated tablet contains; Glipizide ..10 mg Excipients: q.s, Colour: Titanium Dioxide |
||
249 | Glipizide GITs tables 5 mg (gastro intestinal therapeutic sys | Each
film coated tablet contains; Glipizide ..5 mg Excipients: q.s, Colour: Titanium Dioxide |
||
250 | Ibuprofen 400 mg + Paracetamol 325 mg tablets | Each
coated tablet contains; Ibuprofen-400 mg, Paracetamol-325 mg Excipients: QS Colour: Titanium Dioxide |
||
251 | Indapamide Sustained-Release Tablets IP 1.5 mg | Each
film coated tablet contains: Indapamide IP 1.5 mg (As sustained Release Form ) Excipients q.s Colour: Titanium Dioxide IP |
||
252 | Lacosamide Tablets BP 100 mg | Each
film coated tablet contains: Lacosamide BP 100 mg |
||
253 | Lacosamide Tablets BP 150 mg | Each
film coated tablet contains: Lacosamide BP 150 mg |
||
254 | Lacosamide Tablets BP 200 mg | Each
film coated tablet contains: Lacosamide BP 200 mg |
||
255 | Lacosamide Tablets BP 50 mg | Each
film coated tablet contains: Lacosamide BP 50 mg |
||
256 | Lafutidine Tablets 10 mg | Each
Film Coated Tablet Contains: Lafutidine 10 mg Excipients q.s Colour: Titanium dioxide IP |
||
257 | Lafutidine Tablets 5 mg | Each
Film Coated Tablet Contains: Lafutidine 5 mg Excipients q.s Colour: Titanium dioxide IP |
||
258 | Levetiracetam Tablets IP 1000 mg | Each
film coated tablet contains: Levetiracetam IP 1000 mg Excipients q.s. |
||
259 | Levetiracetam Tablets IP 1000 mg | Each
Film Coated Tablet Contains : Levetiracetam IP 1000 mg Excipients q.s Colour: Approved Colour and Titanium Dioxide IP |
||
260 | Levetiracetam Tablets IP 250 mg | Each
film coated tablet contains: Levetiracetam IP 250 mg Excipients q.s. |
||
261 | Levetiracetam Tablets IP 250 mg | Each
Film Coated Tablet Contains : Levetiracetam IP 250 mg Excipients q.s Colour: Approved Colour and Titanium Dioxide IP |
||
262 | Levetiracetam Tablets IP 500 mg | Each
film coated tablet contains: Levetiracetam IP 500 mg Excipients q.s. |
||
263 | Levetiracetam Tablets IP 500 mg | Each
Film Coated Tablet Contains: Levetiracetam IP 500 mg Excipients q.s Colour: Approved Colour and Titanium Dioxide IP |
||
264 | Levetiracetam Tablets IP 750 mg | Each
film coated tablet contains: Levetiracetam IP 750 mg Excipients q.s. |
||
265 | Levetiracetam Tablets IP 750 mg | Each
Film Coated Tablet Contains : Levetiracetam IP 75 mg Excipients q.s Colour: Approved Colour and Titanium Dioxide IP |
||
266 | Levocetrizine 5 mg tablets | Each film coated tablet contains; levocetrizine 2hcl- 5mg | ||
267 | Levocetrizine Di HCl Dispersible tablet 10 mg | Each
uncoated tablet contains: Levocetrizine Di
HCl Eq. to Levocetrizine 10 mg Excipients q.s |
||
268 | Levocetrizine Di HCl Dispersible tablet 5 mg | Each
uncoated tablet contains: Levocetrizine Di
HCl Eq. to Levocetrizine 5
mg Excipients q.s |
||
269 | Levodopa 100 mg + Carbidopa 10 mg Mouth dissolving tablet | Each
uncoated mouth dissolving tablet contains: Levodopa 100 mg Carbidopa 10 mg Excipients q.s |
||
270 | Levodopa 250 mg + Carbidopa 25 mg Mouth dissolving tablet | Each
uncoated mouth dissolving tablet contains: Levodopa 250 mg Carbidopa 25 mg Excipients q.s, |
||
271 | Levosulpiride Tablets 25 mg | Each
uncoated tablet contains: Levosulpiride 25 mg Excipients q.s. |
||
272 | Levosulpiride Tablets 50 mg | Each
uncoated tablet contains: Levosulpiride 50mg Excipients q.s. |
||
273 | Levosulpiride Tablets 75 mg | Each
uncoated tablet contains: Levosulpiride 75 mg Excipients q.s. |
||
274 | Linagliptin tablet 5 mg | Each Film coated Tablet contains: Linagliptin 5 mg Excipients q.s. Colour: Titanium Dioxide | ||
275 | Lithium Carbonate Capsule 250 mg | Each
capsule contains: Lithium Carbonate-250 mg Approved colours used in empty capsule shell |
||
276 | Lithium Carbonate Capsule 300 mg | Each
capsule contains: Lithium Carbonate-300 mg Approved colours used in empty capsule shell |
||
277 | Lithium Carbonate ER Tablets 450 mg | Each
film coated tablet contains: Lithium Carbonate IP 450 mg Excipient: Q.S Colour: Approved Colour & Titanium Dioxide |
||
278 | L-Methylfolate Calcium USP 7.5 mg tablet | Each Film Coated Tablet Contains: L-Methylfolate Calcium USP 7.5 mg Excipients q.s, Colour: Titanium Dioxide | ||
279 | Lorazepam 0.5 mg tablet | Each
mouth dissolving tablet contains Lorazepam IP 0.5 mg |
||
280 | Lorazepam Mouth Dissolving Tablets 1 mg | Each
uncoated mounth dissoling tablets contains Lorazepam IP 1 mg |
||
281 | Lorazepam Mouth Dissolving Tablets 2 mg | Each
uncoated mounth dissoling tablets contains Lorazepam IP 2 mg |
||
282 | Lorazepam Mouth Dissolving Tablets 3 mg | Each
uncoated mounth dissoling tablets contains Lorazepam IP 3 mg |
||
283 | Lorazepam Tablets 3 mg | Each
uncoated Tablets contains Lorazepam IP 3 mg |
||
284 | Lornoxicam 4 mg + Eperisone 50 mg tablet | Each film coated tablet contains: Lornoxicam 4 mg Eperisone 50 mg Excipients q.s, Colour: Titanium dioxide | ||
285 | Lornoxicam 4 mg + Paracetamol 500 mg tablet | Each film coated tablet contains: Lornoxicam 4 mg Paracetamol 500 mg Excipients q.s Colour: Titanium dioxide | ||
286 | Lornoxicam 4 mg + Thiocolchicoside 4 mg Tablets | Each film coated tablet contains: Lornoxicam 4 mg Thiocolchicoside IP 4 mg Excipients q.s Colour: Quinoline Yellow | ||
287 | Lornoxicam 4 mg + Thiocolchicoside 8 mg Tablets | Each film coated tablet contains: Lornoxicam 4 mg Thiocolchicoside IP 8 mg Excipients q.s Colour: Quinoline Yellow | ||
288 | Lornoxicam 8 mg + Thiocolchicoside 4 mg Tablets | Each film coated tablet contains: Lornoxicam 8 mg Thiocolchicoside IP 4 mg Excipients q.s, Colour: Sunset Yellow | ||
289 | Lornoxicam 8 mg + Thiocolchicoside 8 mg Tablets | Each film coated tablet contains: Lornoxicam 8 mg Thiocolchicoside IP 8 mg Excipients q.s, Colour: Yellow oxide iron | ||
290 | Lornoxicam tablet 4 mg | Each film coated tablet contains: Lornoxicam 4 mg Excipients q.s Colour: Titanium dioxide | ||
291 | Lornoxicam tablet 8 mg | Each film coated tablet contains: Lornoxicam 8 mg Excipients q.s Colour: Titanium dioxide | ||
292 | Lycopene, Antioxidents, Multivitamins & Minerals Capsules | Each hard geletinr capsule contains: Lycopene(10%) USP 2000 MCG, Cyanocobolamin IP 15 mcg, Vitamin A acetate IP 5000 I.U, Vitamin C (coated) IP 150 mg, Vitamin E Acetate IP 25 I.U, Zinc sulphate monohydate eq to element zinc 27.45 mg,selenium(as sodium selenite BP) 70 mcg , Vitamin B6 IP 1 mg, folic acid IP 2.5 mg, Magnesium sulphate IP eq to magnesium 65 mcg, Copper sulphate pentahydrate BP eq to element copper 75 mcg, Chromiun chloride Hexahydrate USP eq to elemental chromium 35 mcg, excipient q.s, approved colour used in empty capsule shells | ||
293 | Melatonin tablet 5 mg | Each
uncoated tablet contains: Melatonin 5 mg Excipients: q.s, |
||
294 | Melatonin tablet 5 mg | Each
Coated tablet contains: Melatonin 5 mg Excipients: q.s, |
||
295 | Melatonin Tablets 3 mg | Each
uncoated Tablet contains:
Melatonin BP .. 3 mg, Excipients q.s. |
||
296 | Memantine 10 mg + Donepezil 5 mg Tablets | Each
film coated Tablets Contains Memantine Hydrochloride IP 10 mg Donepezil 5 mg Excipients: QS, Colours: Approved Colour and Titanium Dioxide IP |
||
297 | Memantine 5 mg + Donepezil 5 mg Tablets | Each
film coated Tablets Contains Memantine Hydrochloride IP 5 mg Donepezil 5 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
298 | Memantine Hydrochloride Extended Release Tablets IP 7 mg | Each
film coated Extended Release Tablets Contains Memantine Hydrochloride IP 7 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
299 | Memantine Hydrochloride Extended Release Tablets IP 14 mg | Each
film coated Extended Release Tablets Contains Memantine Hydrochloride IP 14 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
300 | Memantine Hydrochloride Extended Release Tablets IP 21 mg | Each
film coated Extended Release Tablets Contains Memantine Hydrochloride IP 21 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
301 | Memantine Hydrochloride Extended Release Tablets IP 28 mg | Each
film coated Extended Release Tablets Contains Memantine Hydrochloride IP 28 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
302 | Memantine Hydrochloride Tablets IP 10 mg | Each
film coated Tablets Contains Memantine Hydrochloride IP 10 mg Excipients q.s. Colours: Approved Colour and Titanium Dioxide IP |
||
303 | Memantine Hydrochloride Tablets IP 5 mg | Each
film coated Tablets Contains: Memantine Hydrochloride IP 5 mg Excipients q.s. Colours: Ferric Oxide Red USP-NF and Titanium Dioxide IP |
||
304 | Mesalamine Delayed Release Tablets 800 mg | Each delayed release tablet contains: Mesalamine 800 mg Excipients: q.s., Colour: Titanium Dioxide, Red iron oxide | ||
305 | Mesalamine PR Tablets 1.2gm | Each PR tablet contains: Mesalamine 1.2 gm Excipients:.q.s., Colour: Titanium Dioxide, Yellow iron oxide | ||
306 | Metformin 1000 mg + Vildagliptin 50 mg tablet | Each
Fim Coated Tablet Contains:
Metformin Hcl eq. to Metformin 1000 mg Vildagliptin 50 mg Excipients q.s. Colour: Titanium Dioxide |
||
307 | Metformin 500 mg + Repaglinide 1 mg | Each
Bilayer tab contains; Metformin ..500 mg Repaglinide . ...1mg Excipients: q.s, Colour: Ferric Oxide Yellow (in Repaglinide Layer) |
||
308 | Metformin 500 mg + Repaglinide 2 mg | Each
Bilayer tab contains; Metformin ..500 mg Repaglinide . ...2 mg Excipients: q.s, Colour: Ferric Oxide Red (in Repaglinide Layer) |
||
309 | Metformin 500 mg + Vildagliptin 50 mg tablet | Each
Fim Coated Tablet Contains:
Metformin Hcl eq. to Metformin 500 mg Vildagliptin 50 mg Excipients q.s. Colour: Titanium Dioxide |
||
310 | Metformin 850 mg + Vildagliptin 50 mg tablet | Each
Fim Coated Tablet Contains:
Metformin Hcl eq. to Metformin 850 mg Vildagliptin 50 mg Excipients q.s. Colour: Titanium Dioxide |
||
311 | Metformin Hydrochloride Sustained Release Tablets IP 1000 mg | Each
uncoated sustained release tablet contains: Metformin Hydrochloride IP 1000 mg (As Sustained Release form) Excipients q.s. |
||
312 | Metformin Hydrochloride Sustained Release Tablets IP 500 mg | Each
uncoated sustained release tablet contains: Metformin Hydrochloride IP 500 mg (As Sustained Release form) Excipients q.s. |
||
313 | Metformin Hydrochloride Sustained Release Tablets IP 850 mg | Each
uncoated sustained release tablet contains: Metformin Hydrochloride IP 850 mg (As Sustained Release form) Excipients q.s. |
||
314 | Metformin SR tablet 500 mg | Each
uncoated tablet contains:
Metformin HCL eq. to Metformin
500 mg , Excipients q.s. |
||
315 | Methadone Tablets IP 10 mg | Each Film Coated Tablet contains: Methadone Hydrochloride IP 10 mg Excipients: QS ,Colour: Approved Colour & Titanium Dioxide IP | ||
316 | Methadone Tablets IP 20 mg | Each Film Coated Tablet contains: Methadone Hydrochloride IP 20 mg Excipients: QS ,Colour: Approved Colour & Titanium Dioxide IP | ||
317 | Methadone Tablets IP 40 mg | Each Film Coated Tablet contains: Methadone Hydrochloride IP 40 mg Excipients: QS ,Colour: Approved Colour & Titanium Dioxide IP | ||
318 | Methadone Tablets IP 5 mg | Each Film Coated Tablet contains: Methadone Hydrochloride IP 5 mg Excipients: QS ,Colour: Approved Colour & Titanium Dioxide IP | ||
319 | Methylcobalamin 1500 mcg + Alpha lipoic acid 100 mg + Pyridoxine 3 mg + thiamine 10 mg & Folic Acid IP 1.5 mg tablet | Each
Coated tablet contains: Methylcobalamin .. 1500 mcg Alpha lipoic acid 100mg Pyridoxine . 3mg Thiamine 10 mg Folic Acid IP .. . 1.5 mg Excipients: q.s. , Colour: Red Oxide of iron & Titanium Dioxide |
||
320 | Methylcobalamin, alpha Lipoic acid , Thiamine Mononitrate, Pyridoxine Hydrochloride & Folic Acid tablets | each uncoated tablets contains: alpha Lipoic acid USP 100 mg, Pyridoxine Hydrochloride IP 3mg, Methylcobalamin IP 1500 mg , Folic acid IP 1.5 mg, Thiamine Mononitrate IP 10 mg, colous: Red Oxide of iron & Ttitanium dioxide IP appropriate overages of vitamins added | ||
321 | Methylphenidate Hcl E.R Tablet 18 mg | Each uncoated extended release tablet contains; Methylphenidate Hcl USP 18 mg, Excipients q.s. | ||
322 | Methylphenidate Hcl E.R Tablet 36 mg | Each uncoated extended release tablet contains; Methylphenidate Hcl USP 36 mg Excipients q.s. | ||
323 | Methylphenidate Hcl E.R Tablet 54 mg | Each uncoated extended release tablet contains; Methylphenidate Hcl USP 54 mg. Excipients q.s. | ||
324 | Methylphenidate Hcl ER Tablet 10 mg | Each
uncoated ER tablet contains; Methylphenidate Hcl USP . 10 mg Excipients q.s. |
||
325 | Methylphenidate Hcl ER Tablet 20 mg | Each
uncoated ER tablet contains; Methylphenidate Hcl USP .20 mg Excipients q.s. |
||
326 | Methylphenidate Hcl ER Tablet 9 mg | Each
uncoated ER tablet contains;
Methylphenidate Hcl USP
..9 mg Excipients q.s. |
||
327 | Methylphenidate Hcl Tablet 2.5 mg | Each
uncoated tablet contains;
Methylphenidate Hcl USP
.. 2.5 mg Excipients q.s. |
||
328 | Methylphenidate Hcl Tablet 5 mg | Each
uncoated tablet contains;
Methylphenidate Hcl USP
..5 mg, Excipients ..q.s. |
||
329 | Metoprolol Succinate 25 mg Prolonged Release and Amlodipine 2.5 mg Tablets IP | Each Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 23.75 mg Equivalent to Metoprolol Tartrate 25 mg Amlodipine Besylate | ||
330 | Metoprolol Succinate 25 mg Extended Release & Ramipril 2.5 mg Tablets | Each
uncoated bilayered tablet contains: Metoprolol Succinate IP Equivalent to Metoprolol Tartrate 25 mg (As Extended Release) Ramipril IP 2.5 mg Excipients q.s Colour : Sunset Yellow |
||
331 | Metoprolol Succinate 50 mg Prolonged Release and Amlodipine 5 mg Tablets IP | Each
Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 47 mg Equivalent to Metoprolol
Tartrate 50 mg Amlodipine Besylate
IP Equivalent to Amlodipine 5 mg Excipients q.s Colour: Red Oxide of Iron |
||
332 | Metoprolol Succinate Extended Release Tablets IP 200 mg | Each
film coated extended release tablet contains: Metoprolol Succinate IP 190
mg Equivalent to Metoprolol Tartrate 200 mg Excipients q.s Colour: Approved Colour, Titanium Dioxide IP |
||
333 | Metoprolol Succinate Extended Release Tablets IP 50 mg | Each
film coated extended release tablet contains: Metoprolol Succinate IP 47
mg Equivalent to Metoprolol Tartrate 50 mg Excipients q.s Colour: Approved Colour, Titanium Dioxide IP |
||
334 | Metoprolol Succinate Extended Release Tablets IP 100 mg | Each
film coated extended release tablet contains: Metoprolol Succinate IP 95
mg Equivalent to Metoprolol Tartrate 100 mg Excipients q.s Colour: Titanium Dioxide IP |
||
335 | Metoprolol Succinate Extended Release Tablets IP 12.5 mg | Each
Film Coated Extended Release Tablet Contains: Metoprolol Succinate IP 11.875 mg Equivalent to Metoprolol
Tartrate 12.5 mg Excipients q.s Colour: Titanium Dioxide IP |
||
336 | Metoprolol Succinate Extended Release Tablets IP 25 mg | Each
film coated extended release tablet contains: Metoprolol Succinate IP 23.5
mg Equivalent to Metoprolol Tartrate 25 mg Excipients q.s Colour: Approved Colour, Titanium Dioxide IP |
||
337 | Metoprolol Succinate S.R. tablets 25mg. | Each film coated SR tablet contains: Metoprolol Succinate 23.75 mg equivalent to Metoprolol Tartrate 25 mg Excipients: q.s., Colour: Titanium Dioxide | ||
338 | Metoprolol Succinate S.R. tablets 50mg | Each film coated SR tablet contains: Metoprolol Succinate 47.5 mg equivalent to Metoprolol Tartrate 50 mg Excipients: q.s., Colour: Titanium Dioxide | ||
339 | Metoprolol succinate SR tablets 100 mg | Each film coated SR tablet contains: Metoprolol Succinate 95.0 mg equivalent to Metoprolol Tartrate 100 mg Excipients: q.s., Colour: Titanium Dioxide | ||
340 | Metoprolol succinate SR tablets 200 mg | Each film coated SR tablet contains: Metoprolol Succinate 190.0 mg equivalent to Metoprolol Tartrate 200 mg Excipients: q.s., Colour: Titanium Dioxide Excipients: q.s., Colour: Titanium Dioxide | ||
341 | Metoprolol Succinate Tartrate (E.R) 25+ Hydrochlorothiazide 12.5mg Tablet. | Each film coated tablet contains: Metoprolol Succinate 23.75 mg equivalent to Metoprolol Tartrate (ER) 25 mg Hydrochlorothiazide 12.5 mg | ||
342 | Metoprolol Succinate Tartrate (E.R) 50 + Hydrochlorothiazide 12.5 mg Tablet. | Each film Coated tablet contains: Metoprolol Succinate 47.5 mg equivalent to Metoprolol Tartrate (ER) 50 mg Hydrochlorothiazide 12.5 mgExcipients: q.s., Colour: Titanium Dioxide | ||
343 | Metoprolol tartrate Tablet 100 mg | Each
Film coated (SR) tablet contains;
Metoprolol succinate eq.to metoprolol tartrate 100 mg, Excipients q.s. Colour: Titanium Dioxide |
||
344 | Metoprolol tartrate Tablet 50 mg | Each
Film coated (SR) tablet contains;
Metoprolol succinate eq.to metoprolol tartrate 50 mg, Excipients q.s. Colour: Titanium Dioxide |
||
345 | Midodrine Hydrochloride 10 mg Tablet | Each film coated tablet contains; midodrine hydrochloride eq.to midodrine .. 10 mg Excipients: q.s., Colour: Titanium Dioxide | ||
346 | Midodrine Hydrochloride 2.5 mg Tablet | Each film Coated tablet contains: midodrine hydrochloride eq.to Midodrine .. 2.5 mg contains; Midodrine hydrochloride Excipients: q.s., Colour: Titanium Dioxide | ||
347 | Midodrine Hydrochloride 5 mg Tablet | Each film coated tablet contains; midodrine hydrochloride eq.to midodrine ..5mg Excipients: q.s., Colour: Titanium Dioxide | ||
348 | Mirtazapine Tablet 15 mg | Each film coated tablet contains; Mirtazapine- 15 mg Excipients: QS Colour Approved Colour | ||
349 | Mirtazapine Tablet 30 mg | Each film coated tablet contains; Mirtazapine- 30 mg Excipients: QS Colour Approved Colour | ||
350 | Mirtazapine Tablet 45 mg | Each film coated tablet contains; Mirtazapine- 45 mg Excipients: QS Colour Approved Colour | ||
351 | Mirtazapine Tablet 7.5 mg | Each film coated tablet contains; Mirtazapine- 7.5 mg Excipients: QS Colour Approved Colour | ||
352 | Modafinil tablet 100 mg IP | Each uncoated tablet contains; Modafinil IP 100 mg , Excipients q.s. | ||
353 | Modafinil tablet 200 mg IP | Each uncoated tablet contains; Modafinil IP 200 mg , Excipients q.s. | ||
354 | Montelucast 4 mg and Levocetrizine 2.5 mg Tablet | Each
film coated Tablet contains: Montelucast ..4 mg Levocetrizine .. 2.5 mg Excipients .. q.s. |
||
355 | Montelucast Sodium 10 mg and Levocetrizine HCL 2.5 mg Tablet IP | Each
Uncoated bilayered Tablet contains: Montelucast Sodium IP Eq. to montelucast ..10 mg Levocetrizine .. 2.5 mg Excipients .. q.s. Colours: Yellow oxide of Iron & Red oxide of Iron. |
||
356 | Montelucast Sodium 10 mg and Levocetrizine HCL 5 mg Tablet IP | Each
Uncoated bilayered Tablet contains: Montelucast Sodium IP Eq. to Montelucast ..10 mg Levocetrizine .. 5 mg Excipients .. q.s. Colours: Yellow oxide of Iron & Red oxide of Iron. |
||
357 | Montelukast sodium 10 mg & Fexofenadine Hydrochloride 120 mg Tablets | Each
film coated Tablet contains: Montelucast Sodium IP Eq. to Montelucast ..10 mg Fexofenadine Hydrochloride ..... 120 mg Excipients .. . q.s. |
||
358 | Montelukast Sodium 10 mg and Levocetirizine Hydrochloride 5 mgTablets IP | Each
film coated tablet contains: Levocetirizine Hydrochloride IP 5 mg Montelukast Sodium IP Eq. to Montelukast 10 mg Colour: Titanium Dioxide IP |
||
359 | Montelukast Sodium 5 mg and Levocetirizine Hydrochloride 2.5 mg Tablets IP | Each
film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast .5 mg Levocetirizine Hydrochloride IP 2.5 mg Excipients: q.s , Colour: Titanium Dioxide IP, Yellow oxide Iron |
||
360 | Montelukast Sodium Tablets 10 mg | Each
film coated Tablet contains: Montelucast Sodium IP Eq. to Montelucast ..10 mg Excipients .. . q.s. Colours: Titanium Dioxide IP & Yellow oxide of Iron. |
||
361 | Morphine sulphate CR tablets 60 mg | Each film Coated CR tablet contains; Morphine sulphate 60 mg Excipients: QS Colour Approved Colour | ||
362 | Mycophenolate Mofetil Capsule IP 500 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 500 mg Excipients q.s Approved Colour used in EHG Capsule | ||
363 | Mycophenolate Mofetil Capsule IP 250 mg | Each EHG Capsule contains: Mycophenolate Mofetil IP 250 mg Excipients q.s Approved Colour used in EHG Capsule | ||
364 | Mycophenolate Mofetil Tablets IP 180 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 180 mg Excipients q.s Colour : Approved Colour, Titanium Dioxide IP | ||
365 | Mycophenolate Mofetil Tablets IP 250 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 250 mg Excipients q.s Colour : Approved Colour, Titanium Dioxide IP | ||
366 | Mycophenolate Mofetil Tablets IP 360 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 360 mg Excipients q.s Colour : Approved Colour, Titanium Dioxide IP | ||
367 | Mycophenolate Mofetil Tablets IP 500 mg | Each
film coated tablet contains: Mycophenolate Mofetil IP 500 mg Excipients q.s Colour : Ferric Oxide Red USP NF, Titanium Dioxide IP |
||
368 | Mycophenolate Mofetil Tablets IP 500 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 500 mg Excipients q.s Colour : Approved Colour, Titanium Dioxide IP | ||
369 | Mycophenolate Mofetil Tablets IP 750 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 750 mg Excipients q.s Colour : Approved Colour, Titanium Dioxide IP | ||
370 | Mycophenolate Sodium Enteric coated tablet 540 mg | Each film coated tablet contains: Mycophenolate Mofetil IP 540 mg Excipients q.s Approved Colour used in EHG Capsule | ||
371 | Naltexone Hydrochloride Tablet IP 50 mg | Each
film coated tablet contains: Naltexone Hydrochloride IP 50 mg, Excipient q.s. Colour: Ferric Oxide Yellow USP NF & Ferric Oxide Red USP NF |
||
372 | Naltrexone Hydrochloride Tablets IP 50 mg | Each
uncoated tablet contains: Naltrexone Hydrochloride IP 50 mg Excipinets q.s |
||
373 | Nateglinide 120 mg Tablets | Each film coated tab contains; Nateglinide 120 mg Excipients q.s. Colour: Titanium dioxide | ||
374 | Nateglinide 120 mg + Metformin Hydrochloride 500 mg Tablets | Each Film coated tablet contains : Nateglinide U.S.P. 120 mg Metformin Hydrochloride I.P. 500 mg Excipients q.s. Colour: Sunset Yellow | ||
375 | Nateglinide 120 mg and Metformin Hydrochloride (SR) 500 mg Tablets | Each
Film coated SR tablet contains : Nateglinide U.S.P. 120 mg Metformin Hydrochloride I.P. 500 mg, Excipients q.s. Colour: Approved Colour |
||
376 | Nateglinide 120 mg Tablets | Each
Film coated tablet contains : Nateglinide U.S.P. 120 mg Excipients q.s. Colour: Approved Colour |
||
377 | Nateglinide 60 mg Tablets | Each film coated tab contains; Nateglinide 60 mg Excipients q.s. Colour: Titanium dioxide | ||
378 | Nateglinide 60 mg + Metformin Hydrochloride 500 mg Tablets | Each Film coated tablet contains : Nateglinide U.S.P. 60 mg Metformin Hydrochloride I.P. 500 mg Excipients q.s. Colour: Sunset Yellow | ||
379 | Nateglinide 60 mg and Metformin Hydrochloride (SR) 500 mg Tablets | Each
Film coated SR tablet contains : Nateglinide U.S.P. 60 mg Metformin Hydrochloride I.P. 500 mg, Excipients q.s. Colour: Approved Colour |
||
380 | Nateglinide 60 mg Tablets | Each
Film coated tablet contains : Nateglinide U.S.P. 60 mg Excipients q.s. Colour: Approved Colour |
||
381 | Nebivolol | Each
uncoated bilayered tablet contains: Metoprolol Succinate IP Equivalent to Metoprolol Tartrate 50 mg (As Extended Release) Ramipril IP 5 mg Excipients q.s Colour : Sunset Yellow |
||
382 | Nebivolol 5 mg and Hydrochlorothiazide 12.5 mg Tablets | Each
uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Hydrochlorothiazide IP 12.5 mg Excipients q.s |
||
383 | Nebivolol Hydrochloride 5 mg and Amlodipine 2.5 mg Tablets IP | Each
uncoated bilayered tablet contains: Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s |
||
384 | Nebivolol Hydrochloride 5 mg and Amlodipine 5 mg Tablets IP | Each
uncoated bilayered tablet contains: Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s |
||
385 | Nebivolol Tablets IP 5 mg | Each
uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Excipients q.s |
||
386 | Nebivolol Tablets IP 5 mg | Each
uncoated tablet contains: Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg Excipients q.s |
||
387 | Nitrazepam Tablet IP 12.5 mg | Each
uncoated tablet contains: Nitrazepam IP 10 mg Excipients .. q.s. |
||
388 | Nitrazepam Tablet 5 mg | Each
tablet contains: Nitrazepam 5 mg |
||
389 | Nitrazepam Tablet 5 mg | Each
tablet contains: Nitrazepam 5 mg |
||
390 | Nitrofurantoin dispersible tablets 50 mg | Each uncoated dispersible tablet contains; Nitrofurantoin ..50 mg Excipients .q.s. | ||
391 | Nitrofurantoin SR Tablets. 100 mg | Each uncoated sustained release tablet contains: Nitrofurantoin BP 100 mg Excipients : q.s., Colour: Yellow oxide iron | ||
392 | Nitroglycerin 2.6 mg tablet | Each sustained release uncoated tablet contains; Nitroglycerin 2.6 mg Excipients : q.s. | ||
393 | Olanzapine 5 mg And Fluoxetine 20 mg Tablets I.P. | Each
film coated tablets contains Olanzapine IP 5 mg Fluoxetine Hydrochlpride IP Eq. to Fluoxetine 20 mg Excipients q.s |
||
394 | Olanzapine Mouth Dissolving Tablets 10 mg | Each
uncoated mouth dissolving tablets
contains Olanzapine IP 10 mg |
||
395 | Olanzapine Mouth Dissolving Tablets 15 mg | Each
uncoated mouth dissolving tablets
contains Olanzapine IP 15 mg |
||
396 | Olanzapine Mouth Dissolving Tablets 2.5 mg | Each
uncoated mouth dissolving tablets
contains Olanzapine IP 2.5 mg |
||
397 | Olanzapine Mouth Dissolving Tablets 20 mg | Each
uncoated mouth dissolving tablets
contains Olanzapine IP 20 mg Excipients q.s. |
||
398 | Olanzapine Mouth Dissolving Tablets 5 mg | Each
uncoated mouth dissolving tablets
contains Olanzapine IP 5bmg |
||
399 | Olanzapine Mouth Dissolving Tablets 7.5 mg | Each
uncoated mouth dissolving tablets
contains Oxazepam IP 7.5 mg |
||
400 | Omeprazole 20 mg (Enteric coated) + Domperidone 30 mg (S.R.) Capsule | Each filled capsule contains: Omeprazole (EC) 20 mg Domperidone (SR) ... 30 mg Excipients .q.s. | ||
401 | Omeprazole 20mg (EC) + Domperidone 10mg Capsule | Each filled capsule contains: Omeprazole EC . ..20 mg Domperidone . . .. ..10 mg . | ||
402 | Oxaceprol Tablets 200 mg | Each film coated tablet contains: Oxaceprol 200 mg , Excipients q.s. Colour: Tartrazine | ||
403 | Oxazepam tablet 30 MG | Each uncoated Tablet contains: Oxazepam tablet 30 MG. Excipients: QS | ||
404 | Oxazepam tablets IP 10 mg | each uncoated tablets contains: Oxazepam IP 10 mg , excipients q.s | ||
405 | Oxazepam tablets IP 15 mg | each uncoated tablet contains: Oxazepam IP 15 mg, excipients q.s | ||
406 | Oxazepam tablets IP 30 mg | each uncoated tablets contains: Oxazepam IP 30 mg , excipients q.s | ||
407 | Oxcarbazepine 150 mg Tablet | Each film coated tablet contains; Oxcarbazepine 150 mg Excipients: q.s., Colour: Titanium Dioxide, Yellow Oxide Iron | ||
408 | Oxcarbazepine 300 mg Tablet | Each film coated tablet contains; Oxcarbazepine ..................300 mg Excipients: q.s., Colour: Titanium Dioxide, Red Oxide Iron | ||
409 | Oxcarbazepine 600 mg Tablet | Each film coated tablet contains; Oxcarbazepine 600 mg Excipients: q.s., Colour: Titanium Dioxide, Sunset Yellow | ||
410 | Oxcarbazepine SR 150 mg Tablet | Each film coated SR tablet contains; Oxcarbazepine . 150 mg Excipient: q.s., Colour: Titanium Dioxide | ||
411 | Oxcarbazepine SR 300 mg Tablet | Each SR tablet contains; Oxcarbazepine 300 mg Excipients: q.s., Colour: Titanium Dioxide | ||
412 | Oxcarbazepine SR 450 mg Tablet | Each film coated SR tablet contains; Oxcarbazepine 600 mg Excipients: q.s., Colour: Titanium Dioxide, Lake Quinoline Yellow Excipients: q.s., Colour: Titanium Dioxide, Lake Quinoline Yellow | ||
413 | Oxcarbazepine SR 600 mg Tablet | Each SR tablet contains; Oxcarbazepine 600 mg Excipients: q.s., Colour: Titanium Dioxide | ||
414 | Oxcarbazepine SR 900 mg Tablet | Each film coated SR tablet contains; Oxcarbazepine . 900 mg Excipients: q.s., Colour: Titanium Dioxide | ||
415 | Pantoprazole Gastro - resistant Tablets IP 20 mg | Each
gastro - resistant tablet contains: Pantoprazole Sodium IP Eq. to Pantoprazole 20 mg Colours: Approved Colour & Titanium Dioxide IP |
||
416 | Pantoprazole Gastro - resistant Tablets IP 40 mg | Each
gastro - resistant tablet contains: Pantoprazole Sodium IP Eq. to Pantoprazole 40 mg Colours: Approved Colour & Titanium Dioxide IP |
||
417 | Pantoprazole gastro-resistant and domperidone prolonged- release capsules IP | Each hard geletinr capsule contains: Pantoprazole sodium IP eq to pantoprazole 40 mg (as gastro-resistant pellets) , Domperidone IP 30 mg ( as prolonged-release pellets), colours: Lake of indigo carmine & lake of Sunset yellow FCF, Capsule shell colors, coarmoisine, ponceau 4R, Sunset yellow FCF & Titanium dioxide IP, sodium methylparaben IP& sodium propylparaben IP used as preservative | ||
418 | Pantoprazole Mouth Dissolving Tablet 20 mg | Each uncoated tablet contains: Pantoprazole Sodium 20 mg Excipients .q.s. | ||
419 | Pantoprazole Mouth Dissolving Tablet 40 mg | Each uncoated tablet contains: Pantoprazole Sodium 40 mg Excipients .q.s | ||
420 | Pantoprazole Sodium sesquihydrate eq. Pantoprazole 10 mg IR + Domperidone 10mg SR Capsule | Each filled capsule contains: Pantoprazole Sodium sesquihydrate eq. Pantoprazole IR . ..10 mg Domperidone SR.. .. 10mg . | ||
421 | Pantoprazole Sodium sesquihydrate eq. Pantoprazole 40 mg + Domperidone 20 mg Capsule | Each filled capsule contains: Pantoprazole Sodium sesquihydrate eq. Pantoprazole . ..40 mg Domperidone 20mg . | ||
422 | Paracetamol SR Tablets IP 650 mg | Each
uncoated sustained released tablet contains: Paracetamol .650 mg Excipients q.s. |
||
423 | Paracetamol SR Tablets IP 650 mg | Each
uncoated sustained released tablet contains: Paracetamol .650 mg Excipients q.s. |
||
424 | Paracetamol Tablets IP 500 mg | Each
uncoated tablet contains: Paracetamol .500 mg Excipients q.s. |
||
425 | Paroxetine controlled release & clonazepam tablets 12.5 mg & 0.5 mg | each film coated bilayer tablet contains: Paroxetine Hydrochloride hemihydrate IP, eq to Paroxetine 12.5 mg (as controlled release) , clonazepam IP 0.5 mg, excipients q.s | ||
426 | Paroxetine controlled release & clonazepam tablets 25 mg & 0.5 mg | each film coated bilayer tablet contains: Paroxetine Hydrochloride hemihydrate IP, eq to Paroxetine 25 mg (as controlled release) , clonazepam IP 0.5 mg, excipients q.s | ||
427 | Paroxetine Prolonged release tablet IP 12.5 mg | Each
enteric coated prolonged release tablets contains Paroxetine Hydrochloride Hemihydrate IP eq to Paroxetine 12.5 mg colour: sunset yellow FCF, Quinoline yellow WS & Titanium Dioxide |
||
428 | Paroxetine Prolonged release tablet IP 25 mg | Each
enteric coated prolonged release tablets contains Paroxetine Hydrochloride Hemihydrate IP eq to Paroxetine 25 mg colour: sunset yellow FCF, Quinoline yellow WS & Titanium Dioxide |
||
429 | Paroxetine Prolonged release tablet IP 37.5 mg | Each
enteric coated prolonged release tablets contains Paroxetine Hydrochloride Hemihydrate IP eq to Paroxetine 37.5 mg colour: sunset yellow FCF, Quinoline yellow WS & Titanium Dioxide |
||
430 | Paroxetine Prolonged-release Tablets IP 12.5 mg | Each
enteric coated prolonged-release tablets contains Paroxetine Hydrochloride hemihydrate IP eq to paroxetine 12.5 mg |
||
431 | Paroxetine Prolonged-release Tablets IP 25 mg | Each
enteric coated prolonged-release tablets contains Paroxetine Hydrochloride hemihydrate IP eq to paroxetine 25 mg |
||
432 | Paroxetine Prolonged-release Tablets IP 37.5 mg | Each
enteric coated prolonged-release tablets contains Paroxetine Hydrochloride hemihydrate IP 37.5 mg eq to paroxetine 37.5mg |
||
433 | Perindopril 2 mg + Indapamide 0.625 mg Tablet | Each uncoated tablet contains: Perindopril .2 mg, indapamide .. 0.625 mg | ||
434 | Perindopril 4 mg + Indapamide 1.25 mg Tablet | Each uncoated tablet contains: Perindopril .4 mg, indapamide 1.25 mg. | ||
435 | Perindopril Erbumine Tablets IP 4 mg | Each
uncoated tablet contains: Perindopril Erbumine IP 4 mg Excipients q.s |
||
436 | Perindopril Erbumine Tablets IP 8 mg | Each
uncoated tablet contains: Perindopril Erbumine IP 8 mg Excipients q.s |
||
437 | Phenytoin sodium ER Tablets | Each
film coated Tablet contains; phenytoin sodium USP ..300mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
438 | Phenytoin sodium ER Tablets | Each
film coated Tablet contains; phenytoin sodium USP ..300mg Excipients ..q.s. Colour: Approved colour and Titanium Dioxide IP |
||
439 | Phenytoin sodium Tablets IP | Each
film coated Tablet contains; phenytoin sodium ....100mg Excipients ..q.s. Colour: T Approved colour and Titanium Dioxide IP |
||
440 | Phenytoin sodium Tablets IP | Each
film coated Tablet contains; phenytoin sodium ....100mg Excipients ..q.s. Colour: T Approved colour and itanium Dioxide IP |
||
441 | Pioglitazone 15 mg + Metformin 500 mg Tablet | Each
uncoated Bilayer tablet contains; Pioglitazone .. ...15 mg, Metformin ER ..500 mg Excipients q.s, |
||
442 | Pioglitazone 15 mg + Metformin ER 1000 mg tablet | Each
uncoated Bilayer tablet contains; Pioglitazone HCL eq.to Pioglitazone 15 mg, Metformin ER ..1000 mg Excipients: q.s, |
||
443 | Pioglitazone 30 mg + Metformin ER 1000 mg tablet | Each
uncoated Bilayer tablet contains; Pioglitazone HCL eq.to Pioglitazone 30 mg, Metformin ER .. ..1000 mg Excipients: q.s, |
||
444 | Pioglitazone HCL 15 mg + Glimepiride 1 mg Tablet | Each
uncoated tablet contains; Pioglitazone HCL eq.to Pioglitazone 15 mg, Glimepiride ..1 mg Excipients: q.s, |
||
445 | Pioglitazone HCL 15 mg + Glimepiride 2 mg Tablet | Each
uncoated tablet contains; Pioglitazone HCL eq.to Pioglitazone 15 mg, Glimepiride ..2 mg Excipients: q.s, |
||
446 | Pioglitazone HCL Tablet 15 mg | Each
uncoated tablet contains; Pioglitazone HCL eq.to Pioglitazone ..15 mg Excipients q.s, |
||
447 | Pioglitazone HCL Tablet 30 mg | Each
uncoated tablet contains; Pioglitazone HCL eq.to Pioglitazone ..30 mg Excipients q.s, |
||
448 | Pioglitazone HCL Tablet 45 mg | Each
uncoated tablet contains; Pioglitazone HCL eq.to Pioglitazone ..45 mg Excipients q.s, |
||
449 | Pirfenidone Tablets IP 200 mg | Each film coated Tablets Contains: Pirfenidone IP 200 mg Excipients q.s., Colour: Titanium Dioxide IP | ||
450 | Pitavastatin 2 mg and Fenofibrate 67.5 mg Tablets | Each
Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin 2 mg Fenofibrate IP 67.5 mg Excipients q.s. Colour : Approved Colour, Titanium Dioxide IP |
||
451 | Pitavastatin Tablets 1 mg | Each
Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin 1 mg Excipients q.s. Colour : Approved Colour, Titanium Dioxide IP |
||
452 | Pitavastatin Tablets 2 mg | Each
Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin 2 mg Excipients q.s. Colour : Approved Colour, Titanium Dioxide IP |
||
453 | Pitavastatin Tablets 4 mg | Each
Film coated tablet Contains: Pitavastatin Calcium IP Equivalent To Pitavastatin 4 mg Excipients q.s. Colour : Titanium Dioxide IP |
||
454 | Prasugrel Tablets IP 10 mg | Each film coated Tablets Contains: Prasugrel Hydrochloride IP Eq. to Prasugrel 10 mg Colours: Ferric Oxide (Yellow) USP-NF & Titanium dioxide IP | ||
455 | Prasugrel Tablets IP 5 mg | Each film coated Tablets Contains: Prasugrel Hydrochloride IP Eq. to Prasugrel 5 mg Colours: Ferric Oxide (Yellow) USP-NF & Titanium dioxide IP | ||
456 | Prazosin hydrochloride Tablets 1 mg | Each uncoated tablet contains: Prazosin HCL eq.to prazosin 1 mg, Excipients q.s. | ||
457 | Prazosin hydrochloride Tablets 2 mg | Each uncoated tablet contains: Prazosin HCL, eq.to prazosin 2 mg, Excipients q.s. | ||
458 | Pregabalin 75 Mg + Nortriptyline HCL 10 Mg Tab | Each
film Coated tablet contans: Pregabalin . 75 mg Nortriptyline HCL . 10 Mg Excipients: q.s., Colour: Red Oxide of Iron |
||
459 | Pregabalin 75 mg and Methylcobalamin 1500 mcg Capsules IP | Each
hard gelatin capsule contains : Pregabalin IP 75 mg Methylcobalamin IP 750 mcg Capsule shell colours: Carmoisine, Sunset Yellow FCF, Brilliant Blue FCF & Titanium Dioxide IP |
||
460 | Pregabalin 75 mg and Methylcobalamin 750 mcg Capsules IP | Each
hard gelatin capsule contains : Pregabalin IP 75 mg Methylcobalamin IP 750 mcg Capsule shell colours: Carmoisine, Sunset Yellow FCF, Brilliant Blue FCF & Titanium Dioxide IP |
||
461 | Pregabalin capsule 150 mg | Each
EHG Capsule contains: Pregabalin IP 150 mg Excipients q.s, Approved Colour used in EHG |
||
462 | Pregabalin capsule 300 mg | Each
EHG Capsule contains: Pregabalin IP 300 mg Excipients q.s Approved Colour used in EHG |
||
463 | Pregabalin capsule 75 mg | Each
EHG Capsule contains: Pregabalin IP 75 mg Excipients q.s Approved Colour used in EHG |
||
464 | Pregabalin SR Tablet 150 mg | Each Film Coated SR Tablet Contents: Pregabalin 150 mg Excipients q.s Approved Colour | ||
465 | Pregabalin SR Tablet 300 mg | Each Film Coated SR Tablet Contents: Pregabalin 300 mg Excipients q.s Approved Colour | ||
466 | Pregabalin SR Tablet 75 mg | Each Film Coated SR Tablet Contents: Pregabalin 75 mg Excipients q.s Approved Colour | ||
467 | Pregabalin Tablets 150 mg | Each
Film Coated Tablet Contains: Pregabalin IP 150 mg Excipients q.s. Colour: Titanium Dioxide IP |
||
468 | Pregabalin Tablets 300 mg | Each
Film Coated Tablet Contains: Pregabalin IP 300 mg Excipients q.s. Colour: Titanium Dioxide IP |
||
469 | Pregabalin Tablets 75 mg | Each
Film Coated Tablet Contains: Pregabalin IP 75 mg Excipients q.s. Colour: Titanium Dioxide IP |
||
470 | Propranalol tablet 10 mg | Each
uncoated tablet contains: Propranalol Hcl .10 mg Excipients: .q.s |
||
471 | Propranalol tablet 20 mg | Each
uncoated tablet contains: Propranalol Hcl ..20 mg Excipients: ..q.s |
||
472 | Propranalol tablet 40 mg | Each
uncoated tablet contains: Propranalol Hcl ..40 mg Excipients: ..q.s |
||
473 | Propranolol 40 mg (SR Pellets) + Fluarizine 10 mg capsules | Each
Filled Capsule Contains: Propranolol 40 mg (SR Pellets) Fluarizine 10 mg Excipients: ....q.s |
||
474 | Propranolol 40 mg (SR Pellets) + Fluarizine 5 mg capsules | Each
Filled Capsule Contains: Propranolol .40 mg (SR Pellets) Fluarizine 5 mg Excipients: ....q.s |
||
475 | Propranolol Hcl sustained release tablet 160 mg | Each
uncoated SR tablet contains: Propranalol Hcl 160 mg Excipients: ....q.s |
||
476 | Propranolol Hcl sustained release tablet 80 mg | Each
uncoated SR tablet contains: Propranalol Hcl ..80 mg Excipients: .q.s |
||
477 | Quetiapine 25 mg Tablets IP | Each
film coated tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 25 mg |
||
478 | Quetiapine Prolonged-release Tablets BP 100 mg | Each
film coated prolonged release tablet contains Quetiapine Fumarate IP Eq. to Quetiapine 100 mg |
||
479 | Quetiapine Prolonged-release Tablets BP 200 mg | Each
film coated prolonged release tablet contains Quetiapine Fumarate IP Eq. to Quetiapine 200 mg |
||
480 | Quetiapine Prolonged-release Tablets BP 300 mg | Each
film coated prolonged release tablet contains Quetiapine Fumarate IP Eq. to Quetiapine 300 mg |
||
481 | Quetiapine Prolonged-release Tablets BP 400 mg | Each
film coated prolonged release tablet contains: Quetiapine Fumarate IP 400 mg Eq. to Quetiapine 400 mg |
||
482 | Quetiapine Prolonged-release Tablets BP 50 mg | Each
film coated prolonged release tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 50 mg |
||
483 | Rabeprazole Gastro - resistant Tablets IP 20 mg | Each
gastro - resistant tablet contains: Rabeprazole Sodium IP 20 mg Colours: Ferric Oxide (Red) USPNF & Titanium Dioxide IP |
||
484 | Rabeprazole Sodium 20 mg & Sustained Release Levosulpiride 75 mg Capsules | Each
hard gelatin capsule contains: Rabeprazole Sodium IP 20 mg (as enteric coated Pellets) Levosulpiride 75 mg (as sustained release Pellets) |
||
485 | Rabeprazole Sodium 20 mg + Domperidone 30 mg S.R Capsule | Each
Hard Gelatine Capsule contains: Rabeprazole Sodium IP 20 mg (as Pellets) Domperidone Maleate IP 10 mg (as Pellets) Approved colours used in empty capsule shell |
||
486 | Repaglinide 1 mg and Metformin Hydrochloride 500 mg Tablets I.P. | Each film coated tablet contains: Repaglinide IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s, Colour: Yellow oxide of Iron | ||
487 | Repaglinide 2 mg and Metformin Hydrochloride 500 mg Tablets I.P. | Each film coated tablet contains: Repaglinide IP 2 mg Metformin Hydrochloride IP 500 mg Excipients q.s, Colour: Yellow oxide of Iron | ||
488 | Riboflavin IP 200 mg + Elemental Magnisum 200 mg Tablet | Each
film coated tablets Contains: Riboflavin IP .200 mg Heavy Magnesium Oxide e.q. to Elemental Magnesium 200 mg Excipients: q.s, Colour: Titanium Oxide & Sunset Yellow |
||
489 | Rifaximin 200 mg Dispersible Tablets | Each
uncoated Dispersible tablet Contains: Rifaximin 200 MG Excipients q.s. |
||
490 | Rifaximin 200 mg Tablets | Each
uncoated tablet Contains Rifaximin 200 mg Excipients |
||
491 | Rifaximin 400 mg Tablets | Each
uncoated tablet Contains Rifaximin 400 MG Excipients q.s. |
||
492 | Rivaroxaban Tablets 10 mg | Each
film coated tablet contains: Rivaroxaban 10 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
||
493 | Rivaroxaban Tablets 15 mg | Each
film coated tablet contains: Rivaroxaban 15 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
||
494 | Rivaroxaban Tablets 2.5 mg | Each
film coated tablet contains: Rivaroxaban 2.5 mg Excipients q.s Colour : Ferric Oxide Yellow USP-NF & Titanium Dioxide IP |
||
495 | Rivaroxaban Tablets 20 mg | Each
film coated tablet contains: Rivaroxaban 20 mg Excipients q.s Colour : Ferric Oxide Red USP-NF & Titanium Dioxide IP |
||
496 | Ropinirole ER Tablets IP 1 mg | Each film coated ER tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 1 mg Excipients q.s, Colour: Titanium Oxide & Approved Colour | ||
497 | Ropinirole ER Tablets IP 2 mg | Each film coated ER tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 2 mg Excipients q.s, Colour: Titanium Oxide & Approved Colour | ||
498 | Ropinirole ER Tablets IP 4 mg | Each film coated ER tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 4 mg Excipients q.s, Colour: Titanium Oxide & Sunset Yellow | ||
499 | Ropinirole ER Tablets IP 6 mg | Each film coated ER tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 6 mg Excipients q.s Colour: Titanium Oxide & Red iron Oxide | ||
500 | Ropinirole ER Tablets IP 8 mg | Each film coated ER tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 8 mg Excipients q.s Colour: Titanium Oxide & Yellow Iron Oxide | ||
501 | Ropinirole Tablets IP 0.25 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 0.25 mg Excipients q.s, Colour: Titanium dioxide IP | ||
502 | Ropinirole Tablets IP 0.5 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 0.5 mg Excipients q.s, Colour: Quinoline Yellow WS & Brilliant Blue FCF | ||
503 | Ropinirole Tablets IP 1 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 1 mg Excipients q.s , Colour: Quinoline Yellow WS & Brilliant Blue FCF | ||
504 | Ropinirole Tablets IP 2 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 2 mg Excipients q.s, Colour: Quinoline Yellow WS & Brilliant Blue FCF | ||
505 | Ropinirole Tablets IP 5 mg | Each film coated tablet contains: Ropinirole Hydrochloride IP Eq. to Ropinirole 5 mg Excipients q.s, Colour: Quinoline Yellow WS & Brilliant Blue FCF | ||
506 | Rosiglitazone 2 mg + Glimepiride 1 mg tab | Each
film coated tab contains: Rosiglitazone maleate eq.to Rosiglitazone 2 mg, Glimepiride 1 mg Excipients: q.s, Colour: Titanium Dioxide |
||
507 | Rosiglitazone 4 mg + Glimepiride 1 mg tab | Each
film coated tab contains: Rosiglitazone maleate eq.to Rosiglitazone 4 mg Glimepiride 1 mg Excipients: q.s, Colour: Titanium Dioxide |
||
508 | Rosuvastatin 10 mg + Fenofibrate 145 mg Tablet | Each
Film Coated Contains: Rosuvastatin 10 mg Fenofibrate145 mg Colour: Approved Colour |
||
509 | Rosuvastatin 20 mg + Fenofibrate 160 mg Tablet | Each
Film Coated Contains: Rosuvastatin 20 mg Fenofibrate 160 mg Colour: Approved Colour |
||
510 | Rosuvastatin 5 mg + Fenofibrate 67 mg Tablet | Each
Film Coated Contains: Rosuvastatin 5 mg Fenofibrate 67 mg Colour: Approved Colour |
||
511 | Rosuvastatin Calcium tablets 10 mg | Each
Film Coated Contains: Rosuvastatin Calcium 10 mg Colour: Approved Colour |
||
512 | Rosuvastatin Calcium tablets 20 mg | Each
Film Coated Contains: Rosuvastatin Calcium 20 mg Colour: Approved Colour |
||
513 | Rosuvastatin Calcium tablets 40 mg | Each
Film Coated Contains: Rosuvastatin Calcium 40 mg Colour: Approved Colour |
||
514 | Rosuvastatin Calcium tablets 5 mg | Each
Film Coated Contains: Rosuvastatin Calcium 5 mg Colour: Approved Colour |
||
515 | S (-) Amlodipine 2.5 mg + Clopidogrel 75 mg Tablets | Each film coated tab contains: S (-) Amlodipine IP 2.5 mg Clopidogrel IP 75 mg Excipients q.s , Colour : Approved Colour | ||
516 | S (-) Amlodipine 5 mg + Clopidogrel 75 mg Tablets | Each film coated tab contains: S (-) Amlodipine IP 5 mg Clopidogrel IP 75 mg Excipients q.s , Colour : Approved Colour | ||
517 | S-Adenosyl-L Methionine Tablet 200 mg | each film coated tablet contains: S-Adenosyl- L Methionine disulfate, P-Toluenesulfonate Eq To S- Adenosyl-L Methionine Tablet 200 mg , excipients q.s, colour: Titanium dioxide IP | ||
518 | S-Adenosyl-L Methionine Tablet 400 mg | each film coated tablet contains: S-Adenosyl- L Methionine disulfate, P-Toluenesulfonate Eq To S- Adenosyl-L Methionine Tablet 400mg | ||
519 | Saxagliptin tablet 2.5 mg | Each
film coated tablet contains; Saxagliptin hydrochloride eq.to Saxagliptin 2.5 mg Excipients q.s. Colour: Titanium Dioxide |
||
520 | Saxagliptin tablet 5 mg | Each
film coated tablet contains; Saxagliptin hydrochloride eq.to Saxagliptin 5 mg Excipients q.s. Colour: Titanium Dioxide |
||
521 | Sertraline 50 mg & Clonazepam 0.5 mg Tablet | Each
film Coated Tablet Contains: Sertraline Hcl eq. to Sertralin 50 mg Clonazepam IP 0.5 g Colour: Titanium Dioxide |
||
522 | Sertraline Tablet 100 mg | Each film coated tablet contains; Sertraline hcl eq. to Sertraline- 100 mg Excipients: QS Colour Approved Colour | ||
523 | Sertraline Tablet 25 mg | Each film coated tablet contains; Sertraline hcl eq. to Sertraline- 25 mg Excipients: QS Colour Approved Colour | ||
524 | Sertraline Tablet 50 mg | Each film coated tablet contains; Sertraline hcl eq. to Sertraline- 50 mg Excipients: QS Colour Approved Colour | ||
525 | Sertraline Tablets IP 100 mg | Each
film coated Tablet contains; Sertraline HCL IP Eq.to Sertraline .. 100 mg Excipients ..q.s. Colour: Indigocarmine |
||
526 | Sertraline Tablets IP 20 mg | Each
film coated Tablet contains; Sertraline HCL IP Eq.to Sertraline .. 20 mg Excipients ..q.s. Colour: Titanium Dioxide IP |
||
527 | Sertraline Tablets IP 50 mg | Each
film coated Tablet contains; Sertraline HCL IP Eq.to Sertraline .. 50 mg Excipients ..q.s. Colour: Titanium Dioxide IP |
||
528 | Sildenafil Citrate 20 mg Tablet | Each film coated tablet contains: Sildenafil Citrate 20 mg Excipients q.s. Colour: Titanium Dioxide & Brilliant Blue | ||
529 | Sildenafil citrate tablet 100 mg | Each film coated tablets contains: Sildenafil citrate IP 100 mg Excipients q.s , Colours: Brilliant Blue & Titanium Dioxide IP | ||
530 | Sildenafil citrate tablet 25 mg | Each film coated tablets contains: Sildenafil citrate IP 25 mg Excipients q.s , Colours: Brilliant Blue & Titanium Dioxide IP | ||
531 | Sildenafil citrate tablet 50 mg | Each film coated tablets contains: Sildenafil citrate IP 50 mg Excipients q.s , Colours: Brilliant Blue & Titanium Dioxide IP | ||
532 | Sitagliptin 50 mg + Metformin 1000 mg tablet | Each
Film coated tablet contains: Sitagliptin ( As Phosphate) 50 mg Metformin Hcl. 1000 mg Excipients q.s. Colour: Titanium Dioxide |
||
533 | Sitagliptin 50 mg + Metformin 500 mg tablet | Each
Film coated tablet contains: Sitagliptin ( As Phosphate) 50 mg Metformin Hcl. 500 mg Excipients q.s. Colour: Titanium Dioxide |
||
534 | Sodium Valproate 499.5 mg + Valproic acid 217.5 mg equivalent as sodium valproate- 750 mg CR tablet | Each film coated Controled release tablet contains: Sodium Valproate 499.5 mg Valproic acid 217.5 mg Excipients q.s. ,Colour: Titanium Dioxide & Quinoline Yellow | ||
535 | Sodium Valproate 666 mg + valproic acid 290 mg equivalent as sodium valproate 1000 mg C.R. Tablet | Each film coated Controled release tablet contains: Sodium Valproate 666 mg Valproic acid 290 mg Excipients q.s. ,Colour: Titanium Dioxide & Red iron oxide | ||
536 | Solifenacin Succinate Tablets IP 10 mg | Each
film coated tablet contains: Solifenacin Succinate IP 10 mg Excipients q.s Colour : Ferric Oxide USP NF Red & Titanium Dioxide IP |
||
537 | Solifenacin Succinate Tablets IP 5 mg | Each
film coated tablet contains: Solifenacin Succinate IP 5 mg Excipients q.s Colour : Ferric Oxide USP NF Yellow & Titanium Dioxide IP |
||
538 | Sustained Release Propranolol hydrochloride & Flunarzine Dihydrochloride Tablets | Each
uncoated bilayered tablet contains: Propranolol Hydrochloride IP 40 mg (as extended release form) Flunarzine Dihydrochloride BP Eq.to Flunarzine .. ....10 mg Excipients ..q.s Colour: Sunset yellow FCF. |
||
539 | Tadalafil 10 mg & Dapoxetine 30 mg Tablets | Each
film coated tablet contains: Tadalafil IP 10 mg Dapoxetine Hydrochloride IP eq. to Dapoxetine 30 mg |
||
540 | Tadalafil Tablets IP 10 mg | Each
film coated tablet contains: Tadalafil IP 10 mg |
||
541 | Tadalafil Tablets IP 20 mg | Each
film coated tablet contains: Tadalafil IP 20 mg |
||
542 | Tadalafil Tablets IP 5 mg | Each
film coated tablet contains: Tadalafil IP 5 mg |
||
543 | Tapentadol Extended release tablet 100 mg | each film coated extended release tablet contains: Tapentadol Hydrochloride IP eq to Tapentadol 100 mg, colour: Tiotanium dioxide IP | ||
544 | Tapentadol Extended release tablet 150 mg | each film coated extended release tablet contains: Tapentadol Hydrochloride IP eq to Tapentadol 150 mg, colour: Tiotanium dioxide IP | ||
545 | Tapentadol Extended Release Tablet 50 mg | Each Coated Extended released tablet
contains: Tapentadol 50 mg Excipients q.s. |
||
546 | Tapentadol Tablet 100 mg | each film coated tablet contains: Tapentadol Hydrochloride IP eq to Tapentadol 1000 mg , colour: Titanium dioxide IP | ||
547 | Tapentadol Tablet 50 mg | each film coated tablet contains: Tapentado Hydrochloride IP eq to Tapentado 50 mg , colour: Titanium dioxide IP | ||
548 | Tapentadol Tablet 75 mg | each film coated tablet contains: Tapentado Hydrochloride IP eq to Tapentado 75 mg , colour: Titanium dioxide IP | ||
549 | Telmisartan 20 mg (Immediate Release) and Metoprolol 25 mg (Extended Release)Tablets | Each
uncoated Bilayered Tablet Contains: Telmisartan IP 20 mg (In Immediate Release Form) Metoprolol Succinate IP 23.5 mg Equivalent to Metoprolol Tartrate 25 mg (In Extended Release Form) Excipien : QS, Colour: Sunset Yellow (In Metoprolol Layer) |
||
550 | Telmisartan 20 mg Tablet | Each
Uncoated Tablet contains: Telmisartan 20 mg |
||
551 | Telmisartan 40 mg & Amlodipine Besilate 5 mg Tablet | Each
Uncoated Bilayer Tablet Contains: Telmisartan 40 mg Amlodipine Besilate Eq to Amlodipine 5 mg Colour: Approved Colour |
||
552 | Telmisartan 40 mg (Immediate Release) and Metoprolol 50 mg (Extended Release)Tablets | Each
uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg (In Immediate Release Form) Metoprolol Succinate IP 47.5 mg Equivalent to Metoprolol Tartrate 50 mg (In Extended Release Form) Excipients q.s Colour: Sunset Yellow (In Metoprolol Layer) |
||
553 | Telmisartan 40 mg and Amlodipine 10 mg Tablets | Each
Film coated Bilayered Tablet Contains: Telmisartan IP 40 mg Amlodipine Besylate IP Equivalent to Amlodipine 10 mg Excipients q.s Colour: Red Oxide of Iron and Titanium Dioxide IP |
||
554 | Telmisartan 40 mg Tablet | Each
Uncoated Tablet contains: Telmisartan 40 mg |
||
555 | Telmisartan 80 mg & Amlodipine 5 mg Tablets | Each
film coated tablet contains: Amlodipine besylate eq to Amlodipine IP 5 mg Telmisartan IP 80 mg Excipients q.s Colour : Approved Colour & Titanium Dioxide IP |
||
556 | Telmisartan 80 mg and Amlodipine 10 mg Tablets IP | Each Uncoated Tablet Contains: Telmisartan IP 80 mg Amlodipine Besilate IP Eq. to Amlodipine 10 mg Excipients q.s. | ||
557 | Telmisartan 80 mg and Amlodipine 10 mg Tablets IP | Each Uncoated Tablet Contains: Telmisartan IP 80 mg Amlodipine Besilate IP Eq. to Amlodipine 10 mg Excipients : q.s. | ||
558 | Telmisartan 80 mg Tablet | Each
Uncoated Tablet contains: Telmisartan 80 mg |
||
559 | Telmisartan and Hydrochlorothiazide Tablets IP 40 mg /12.5 mg | Each Film coated bi-layered Tablet Contains : Telmisartan IP 40 mg Hydrochlorothiazide IP 12.5mg Excipients q.s. Colour: sunset yellow IP | ||
560 | Telmisartan and Hydrochlorothiazide Tablets IP 80 mg /12.5 mg | Each Film coated bi-layered Tablet Contains : Telmisartan IP 80 mg Hydrochlorothiazide IP 12.5 mg Excipients q.s. Colour: Approved Colour IP | ||
561 | Teneligliptin Tablets IP 20 mg | Each
Film Tablet Contains: Teneligliptin Hydrobromide Hydrate IP Equivalent to Teneligliptin 20 mg Excipients q.s. Colour: Approved Colour & Titanium Dioxide IP |
||
562 | Tenofovir Disoproxil Fumarate (300mg) + Emtricitabine (200mg) tablet | Each
Film Coated Tablet Contains:+ Tenofovir Disoproxil Fumarate IP 300 mg Emtricitabine 200 mg Excipients q.s. Colour: Approved Colour Titanium Dioxide IP |
||
563 | Tenofovir disoproxil fumarate 300 mg + Lamivudine 300 mg tablet | Each
Film Coated Tablet Contains: Tenofovir Disoproxil Fumarate IP 300 mg Lamivudine 300 mg Excipients q.s. Colour: Approved Colour Titanium Dioxide IP |
||
564 | Tenofovir Disoproxil Fumarate Tablets IP 300 mg | Each
Film Coated Tablet Contains: Tenofovir Disoproxil Fumarate IP 300 mg Excipients q.s. Colour: Approved Colour, Titanium Dioxide IP |
||
565 | Thiocolchicoside 4 mg + Aceclofenac 100 mg Tablets | Each film coated tablet contains: Thiocolchicoside IP 4 mg Aceclofenac IP 100 mg Excipients q.s. Colour: Quinoline Yellow | ||
566 | Thiocolchicoside 4 mg and Aceclofenac 100 mg Tablets | Each film coated tablet contains: Thiocolchicoside IP 4 mg Aceclofenac IP 100 mg Excipients q.s. Colour: Quinoline Yellow | ||
567 | Thiocolchicoside 8 mg + Etoricoxib 60 mg tablets | Each film coated tablet contains: Thiocolchicoside IP 4 mg Etoricoxib IP 60 mg Excipients q.s. Colour: Quinoline Yellow | ||
568 | Ticagrelor Tablet 90 mg | Each
Film Coated Contains: Ticagrelor 90 mg Colour: Approved Colour |
||
569 | Tolperisone Hydrochloride 150 mg + Diclofenac Sodium 50 mg Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Diclofenac Sodium 50 mg Excipients q.s., Colour : Titanium dioxide IP | ||
570 | Tolperisone Hydrochloride 150 mg + Paracetamol 500 mg Tablets | Each film coated tablet contains: Tolperisone Hydrochloride 150 mg Paracetamol IP 500 mg Excipients q.s., Colour : Titanium dioxide IP | ||
571 | Tolperisone Hydrochloride 450 mg & Diclofenac Sodium 100 mg (ER) Tablets | Each film coated bilayered extended release tablet contains: Tolperisone Hydrochloride 450 mg Diclofenac Sodium IP 100 mg Excipients q.s., Colour : Sunset Yellow FCF | ||
572 | Tolperisone Hydrochloride Sustained Release Tablets 450 mg | Each film coated Sustained Release tablet contains: Tolperisone Hydrochloride 450 mg Excipients q.s., Colour : Ferric Oxide (Yellow) USP-NF | ||
573 | Topiramate Tablets IP 100 mg | Each
film coated tablet contains: Topiramate IP 100 mg Excipients q.s. |
||
574 | Topiramate Tablets IP 200 mg | Each
film coated tablet contains: Topiramate IP 200 mg Excipients q.s. Colour: Titanium Dioxide & Approved Colour |
||
575 | Topiramate Tablets IP 25 mg | Each
film coated tablet contains: Topiramate IP 25 mg Excipients q.s. Colour: Titanium Dioxide & Sunset Yellow |
||
576 | Topiramate Tablets IP 300 mg | Each
film coated tablet contains: Topiramate IP 300 mg Excipients q.s. Colour: Titanium Dioxide & Approved Colour |
||
577 | Topiramate Tablets IP 400 mg | Each
film coated tablet contains: Topiramate IP 400 mg Excipients q.s. Colour: Titanium Dioxide & Approved Colour |
||
578 | Topiramate Tablets IP 50 mg | Each
film coated tablet contains: Topiramate IP 50 mg Excipients q.s. |
||
579 | Torsemide 10 mg + Amiloride 5 mg tablets | Each uncoated tablet contains: Torsemide IP 10 mg Amiloride 5 mg , Excipients q.s. | ||
580 | Tramadol HCL 37.5 mg + Paracetamol 325 mg tablet | Each
film coated tab contains; tramadol hcl-37.5mg Paracetamol-325 mg Excipients: QS Colour: Titanium Dioxide & Approved Colour |
||
581 | Tramadol Hcl IP (As Immediate Release Layer) 50mg + Diclofenac Sodium IP (As Sustained Release Layer) 75mg Tablets | Each
film coated IR/SR tab contains; Tramadol HCL- 50 mg Diclofenac Sodium -75 mg Excipients: QS Colour: Titanium Dioxide |
||
582 | Tramadol Hydrochloride Capsule 100 mg | Each
Hard gelatin capsule contains: Tramadol Hydrochloride IP ..........100 mg Excipients .. q.s. |
||
583 | Tramadol Hydrochloride Capsule 100 mg | Each
Hard gelatin capsule contains: Tramadol Hydrochloride IP ..........100 mg Excipients .. q.s. |
||
584 | Tramadol Hydrochloride Capsule 50 mg | Each
Hard gelatin capsule contains: Tramadol Hydrochloride IP ..........50 mg Excipients ... q.s. |
||
585 | Tramadol Hydrochloride Capsule 50 mg | Each
Hard gelatin capsule contains: Tramadol Hydrochloride IP ..........50 mg Excipients .. q.s. |
||
586 | Tramadol Hydrochloride ER Capsule 400 mg | Each
ER Hard gelatin capsule contains: Tramadol Hydrochloride IP ..........400 mg Excipients ... .. q.s. |
||
587 | Valsartan 160 mg + Hydrochlorothiazide 12.5 mg tablets IP | Each film coated tablet contains: Valsartan 160 mg Hydrochlorothiazide 12.5 mg Excipients q.s. , Colour: Titanium Dioxide & Red Oxide of iron | ||
588 | Valsartan 160 mg + Hydrochlorothiazide 25 mg tablets | Each film coated tablet contains: Valsartan 160 mg Hydrochlorthiazide 25 mg Excipients q.s. , Colour: Titanium Dioxide | ||
589 | Valsartan 80 mg + Hydrochlorthiazide 12.5 mg tablets IP | Each film coated tablet contains: Valsartan 80 mg Hydrochlorthiazide 12.5 mg Excipients q.s. Colour: Titanium Dioxide & Yellow Oxide of iron | ||
590 | Valsartan Tablets I.P. 160 mg | Each
Film Coated tablet contains: Valsartan IP 160 mg Excipients q.s Colour: Approved Colour |
||
591 | Valsartan Tablets I.P. 40 mg | Each
Film Coated tablet contains: Valsartan IP 40 mg Excipients q.s Colour: Yellow Oxide of Iron |
||
592 | Valsartan Tablets I.P. 80 mg | Each
Film Coated tablet contains: Valsartan IP 80mg Excipients q.s Colour: Approved Colour |
||
593 | Vildagliptin 50 mg + Metformin Hcl 850 mg tablets IP | Each film coated tablet contains: Vildagliptin 50 mg Metformin Hcl 850 mg Excipients q.s. Colour: Titanium Dioxide & Red Oxide of iron, Yellow Oxide of iron | ||
594 | Vildagliptin 50 mg + Metformin Hcl 1000 mg tablets IP | Each film coated tablet contains: Vildagliptin 50 mg Metformin Hcl 1000 mg Excipients q.s. Colour: Titanium Dioxide & Red Oxide of iron, Yellow Oxide of iron | ||
595 | Vildagliptin 50 mg + Metformin Hcl 500 mg tablets IP | Each film coated tablet contains: Vildagliptin 50 mg Metformin Hcl 500 mg Excipients q.s. Colour: Titanium Dioxide & Red Oxide of iron, Yellow Oxide of iron | ||
596 | Voglibose 0.2 mg + Metformin 500 mg Tablets | Each
uncoated Bilayer Tablet contains: Voglibose IP 0.2 mg Metformin IP 500 mg Excipients q.s |
||
597 | Voglibose 0.2mg tablet (Mouth dissolving) | Each
uncoated Mouth Dissolving tablet
contains: Voglibose IP 0.2 mg Excipients q.s |
||
598 | Voglibose 0.3 mg + Metformin (SR) 500 mg | Each
uncoated Bilayer SR Tablet contains: Voglibose IP 0.3 mg Metformin IP 500 mg Excipients q.s |
||
599 | Voglibose 0.3 mg + Metformin 500 mg Tablets | Each
uncoated Bilayer Tablet contains: Voglibose IP 0.3 mg Metformin IP 500 mg Excipients q.s |
||
600 | Voglibose 0.3mg tablet (Mouth dissolving) | Each
uncoated Mouth Dissolving tablet
contains: Voglibose IP 0.3 mg Excipients q.s |
||
601 | Voglibose dispersible tablet 0.2 mg | Each
uncoated Dispersible tablet
contains: Voglibose IP 0.2 mg Excipients q.s |
||
602 | Voglibose dispersible tablet 0.3 mg | Each
uncoated Dispersible tablet
contains: Voglibose IP 0.3 mg Excipients q.s |
||
603 | Voglibose tablet 0.2 mg | Each
uncoated tablet contains;
voglibose 0.2mg, Excipients q.s. |
||
604 | Voglibose tablet 0.3 mg | Each uncoated tablet contains; voglibose 0.3mg, Excipients q.s. | ||
605 | Voglibose Tablets IP 0.2 mg | Each
uncoated tablet contains: Voglibose IP 0.2 mg Excipients q.s |
||
606 | Voglibose Tablets IP 0.3 mg | Each
uncoated tablet contains: Voglibose IP 0.3 mg Excipients q.s |
||
607 | Vortioxetine Hydrobromide tablet 10 mg | Each film coated tablet contains: Vortioxetine Hydrobromide 10 mg Excipients: QS Colour Approved Colour | ||
608 | Vortioxetine Hydrobromide tablet 15 mg | Each film coated tablet contains: Vortioxetine Hydrobromide 15 mg Excipients: QS Colour Approved Colour | ||
609 | Vortioxetine Hydrobromide tablet 20 mg | Each film coated tablet contains: Vortioxetine Hydrobromide 20 mg Excipients: QS Colour Approved Colour | ||
610 | Vortioxetine Hydrobromide tablet 5 mg | Each film coated tablet contains: Vortioxetine Hydrobromide 5 mg Excipients: QS Colour Approved Colour | ||
611 | Zolpidem tablets IP 10 mg | each fim coated tablet contains: zolpidem tartrate IP 10 mg, excipients q.s, colour: Titanium dioxide IP | ||
612 | Zolpidem tablets IP 5 mg | each fim coated tablet contains: zolpidem tartrate IP 5 mg, excipients q.s, colour: Titanium dioxide IP | ||
613 | Zolpidem Tartrate Prolonged Release Tablets IP 12.5 mg | Each
film coated prolonged release tablet contains: Zolpidem tartrate IP 12.5 mg Excipients: q.s, Colour: Approved colure |
||
614 | Zolpidem Tartrate Prolonged Release Tablets IP 6.2 mg | Each
fim coated prolonged release tablet contains: Zolpidem tartrate IP 6.2 mg Excipients: q.s, Colour: Approved colure |
||
615 | Gabapentin Tablets IP 300 mg | Each film coated tablet contains: Gabapentin IP ..300 mg Excipients q.s. Colour: Red Oxide of Iron & Titanium Dioxide IP | ||
616 | Gabapentin Tablets IP 400 mg | Each film coated tablet contains: Gabapentin IP ..400 mg Excipients q.s. Colour: Red Oxide of Iron & Titanium Dioxide IP | ||
617 | Rabeprazole Sodium 20 mg and Domperidone 30 mg S.R C | Each Hard Gelatine Capsule contains: Rabeprazole Sodium (as Enteric coated Pellets) 20 mg Domperidone (as Sustained Released Pellets) ..30 mg | ||
618 | Zopiclone Tablet 7.5 mg | Each film coated tablet contains: Zopiclone IP 7.5 mg Excipients ..q.s. Colour: Titanium Dioxide IP | ||
619 | Eszopiclone tablet 1 mg | Each film coated tablet contains: Eszopiclone USP 1 mg Excipients : q.s., Colour: Titanium Dioxide IP | ||
620 | Eszopiclone tablet 2 mg | Each film coated tablet contains: Eszopiclone USP 2 mg Excipients:.q.s. Colour: Titanium Dioxide IP | ||
621 | Eszopiclone tablet 3 mg | Each film coated tablet contains: Eszopiclone USP 3 mg Excipients :.q.s. Colour: Titanium Dioxide IP | ||
622 | Dapoxetine Tablets IP 30 mg | Each film coated tablet contains: Dapoxetine Hydrochloride IP Eq.to Dapoxetine 30 mg Excipients :q.s. Colour: Brilliant blue | ||
623 | Dapoxetine Tablets IP 60 mg | Each film coated tablet contains: Dapoxetine Hydrochloride IP Eq.to Dapoxetine 60 mg Excipients: q.s. Colour: Brilliant blue | ||
624 | Risperidone Tablets 1 mg | Each film coated tablet Contains: Risperidone IP .1 mg Excipients ..q.s., Colour: Titanium Dioxide IP | ||
625 | Risperidone Orally Disintegrating Tablets USP 4 mg | Each uncoated orally disintegrating tablet contains: Resperidone IP ......................................... 4 mg Excipients .q.s. Colour: Titanium Dioxide IP | ||
626 | Risperidone Orally Disintegrating Tablets USP 2 mg | Each uncoated orally disintegrating tablet contains: Resperidone IP ......................................... 2 mg Excipients:.q.s., Colour: Titanium Dioxide IP | ||
627 | Risperidone Orally Disintegrating Tablets USP 3 mg | Each uncoated orally disintegrating tablet contains: Resperidone IP ......................................... 3 mg Excipients: q.s. Colour:Sunset Yellow FCF | ||
628 | Risperidone Orally Disintegrating Tablets USP 1 mg | Each uncoated orally disintegrating tablet contains: Resperidone IP ......................................... 1 Excipients :.q.s. Colour : Sunset Yellow FCF | ||
629 | Primidone Tablets USP 25 mg | Each film coated tablet Contains: Primidone USP .25 mg Excipients: q.s. Colours: Ponceau 4R | ||
630 | Primidone Tablets USP 50 mg | Each uncoated tablet contains: Primidone USP ............................................ 50 mg Excipients : q.s. Colour: Titanium Dioxide IP | ||
631 | Primidone Tablets USP 125 mg | Each uncoated tablet contains: Primidone USP ............................................ 125 mg Excipients: q.s., Colour: Titanium Dioxide IP | ||
632 | Paracetamol 325 mg and Tramadol 50 mg tablets | Each film coated tablet contains; Diclofenac Sodium .. 50 mg, Paracetamol . 325 mg Excipients: q.s. Colours: Titanium Dioxide IP | ||
633 | Melatonin Tablet 3 mg | Each uncoated mouth dissolving tablet Contains: Melatonin BP 3 mg Excipients: QS | ||
634 | Azithromycin 250 mg Tablet IP | Each film coated tablets Contains: Azithromycin Dihydrate IP eq. to Azithromycin 250 mg Excipients q.s, Colour: Titanium dioxide & Ferric Oxide Yellow | ||
635 | Azithromycin 500 mg Tablet IP | Each film coated tablets Contains: Azithromycin Dihydrate IP eq. to Azithromycin 500 mg Excipients q.s, Colour: Titanium dioxide & Ferric Oxide Yellow | ||
636 | Clopidogrel Tablet IP 75 mg | Each film coated tab contains; Clopidogrel bisulphate IP eq.to Clopidogrel ..75 mg Excipients q.s, Colour: Titanium dioxide | ||
637 | Clopidogrel Tablet 150 mg | Each film coated tab contains; Clopidogrel bisulphate IP eq.to Clopidogrel .150 mg Excipients q.s, Colour: Titanium dioxide | ||
638 | Clopidogrel Tablet 300 mg | Each film coated tab contains; Clopidogrel bisulphate IP eq.to Clopidogrel ..300 mg Excipients q.s, Colour: Titanium dioxide | ||
639 | Finasteride Tablet IP 1 mg | Each film coated tablet contains; Finasteride IP .1 mg Excipients q.s, Colour: Titanium dioxide | ||
640 | Finasteride Tablet IP 5 mg | Each film coated tablet contains; Finasteride IP .5 mg Excipients q.s, Colour: Titanium dioxide, Sunset Yellow | ||
641 | Glibenclamide 2.5 mg + Metformin 500 mg tablet IP | Each uncoated tablet contains; Glibenclamide IP 2.5 mg Metformin Hcl eq. to Metformin IP .. 500 mg Excipients q.s | ||
642 | Glibenclamide 5 mg + Metformin 500 mg tablet IP | Each uncoated tablet contains; Glibenclamide IP . 5 mg Metformin Hcl eq. to Metformin IP ..500 mg Excipients q.s | ||
643 | L-Methylfolate Calcium 5.6 mg + Mecobalamin 2 mg + Acet | Each Film Coated Tablet Contains: L-Methylfolate Calcium USP ..5.6 mg Mecobalamin IP 2 mg Acetylcysteine .. 600 mg Excipients q.s, Colour: Titanium Dioxide | ||
644 | Piracetam 800 mg + Citicoline Sodium 500 mg Tablet | Each film coated tablets Contains: Piracetam IP 800 mg Citicoline Sodium IP eq. to Citicoline . 500 mg Excipients q.s, Colour: Titanium dioxide | ||
645 | Tamsulosin 0.4 mg + Dutasteride 0.5 mg tablets | Each film coated tablets Contains: Tamsulosin Hcl IP eq to Tamsulosin .. 0.4 mg Dutasteride IP . . 0.5 mg Excipients q.s, Colour: Titanium dioxide | ||
646 | Amlodipine and Atenolol tablets | Each uncoated tablet contains: Amlodipine besylate IP eq. to Amlodipine .. 2.5 mg Atenolol IP 25 mg | ||
647 | Amlodipine and Atenolol tablets | Each uncoated tablet contains: Amlodipine besylate IP eq. to Amlodipine .. 2.5 mg Atenolol IP 50 mg | ||
648 | Amlodipine and Atenolol tablets | Each uncoated tablet contains: Amlodipine besylate IP eq. to Amlodipine .. 5 mg Atenolol IP 50 mg | ||
649 | Escitalopram 20 mg + Clonazepam 0.25 mg Tablet IP | Each Film Coated Tablet contains: Escitalopram Oxalate IP eq. to Escitalopram .. .20 mg Clonazepam IP ..0.25 mg Excipients q.s, Colour: Titanium dioxide | ||
650 | Escitalopram 20 mg + Clonazepam 0.5 mg Tablet IP | Each Film Coated Tablet contains: Escitalopram Oxalate IP eq. to Escitalopram .. .20 mg Clonazepam IP ..0.5 mg Excipients q.s, Colour: Titanium dioxide | ||
651 | Aripiprazole tablet IP 5 mg | Each uncoated tablet contains; Aripiprazole IP 5 mg Excipients q.s | ||
652 | Aripiprazole tablet IP 10 mg | Each uncoated tablet contains; Aripiprazole IP 10 mg Excipients q.s | ||
653 | Aripiprazole tablet IP 15 mg | Each uncoated tablet contains; Aripiprazole IP 15 mg Excipients q.s | ||
654 | Aripiprazole tablet IP 20 mg | Each uncoated tablet contains; Aripiprazole IP 20 mg Excipients q.s | ||
655 | Aripiprazole tablet IP 30 mg | Each uncoated tablet contains; Aripiprazole IP 30 mg Excipients q.s | ||
656 | Sertraline + Clonazepam Tablets | Each Film coated tablet contains: Sertraline HCL IP eq. to Sertraline . 50 mg Clonazepam IP 0.5 mg Colour: Titanium Dioxide IP | ||
657 | Olmesartan Medoxomil 20 mg + Amlodipine Besylate 5 mg | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 20 mg Amlodipine Besylate IP eq to Amlodipine . 5 mg Excipients: q.s., Colour: Titanium Dioxide IP | ||
658 | Olmesartan 40 mg + Amlodipine 5 mg | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 40 mg Amlodipine Besylate IP eq to Amlodipine . 5 mg Excipients: q.s., Colour: Titanium Dioxide IP & Red Oxide of Iron | ||
659 | Olmesartan Medoxomil 5 mg Tablet IP | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 5 mg Excipients: q.s., Colour: Titanium Dioxide IP | ||
660 | Olmesartan Medoxomil 10 mg Tablet IP | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 10 mg Excipients: q.s., Colour: Titanium Dioxide IP & Sunset Yellow | ||
661 | Olmesartan Medoxomil 20 mg Tablet IP | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 20 mg Excipients: q.s., Colour: Titanium Dioxide IP & Yellow Oxide of Iron | ||
662 | Olmesartan Medoxomil 40 mg Tablet IP | Each Film coated tablet contains: Olmesartan Medoxomil IP .. 40 mg Excipients: q.s., Colour: Titanium Dioxide IP & Red Oxide of Iron | ||
663 | Calcium and Vitamin D3 Tablet IP | Each Film coated tablet contains: Calcium Citrate Malate IP eq to Elemental Calcium .. 250 mg Vitamin D3 IP 1000 IU Colour: Titanium Dioxide IP |